Method of forming a nitrogen-containing carbon film and system for performing the method

Information

  • Patent Grant
  • 12068154
  • Patent Number
    12,068,154
  • Date Filed
    Thursday, April 8, 2021
    3 years ago
  • Date Issued
    Tuesday, August 20, 2024
    3 months ago
Abstract
Methods and systems for forming a forming a nitrogen-containing carbon film and structures formed using the methods or systems are disclosed. Exemplary methods include providing a precursor with carbon-terminated carbon-nitrogen bonds. The methods can further include providing a reactant to the reaction chamber.
Description
FIELD OF INVENTION

The present disclosure generally relates to methods suitable for use in the manufacture of electronic devices. More particularly, examples of the disclosure relate to methods of forming nitrogen-containing carbon films, to methods of forming structures including such films, and to systems for performing the methods and/or forming the structures.


BACKGROUND OF THE DISCLOSURE

Nitrogen-containing carbon films can be used in a variety of applications during the manufacture of electronic devices. For example, nitrogen-containing carbon films can be used as optical films, as etching hard mask films, as a gap-fill film for trench patterns, and the like. For some applications, etching resistance, chemical mechanical planarization (CMP) resistance and/or thermal stability may desirably be relatively high. The incorporation of nitrogen in the nitrogen-containing carbon films can produce carbon-containing films that exhibit superior properties, such as increased etch resistance, increased CMP resistance, and/or thermal stability, compared to films that do not include the nitrogen containing material.


For some applications, the nitrogen-containing carbon films may desirably be formed using a plasma process. Use of a plasma process can allow for lower temperatures during the film deposition and/or increased deposition rates of the nitrogen-containing carbon films, compared to thermal processes.


Traditional plasma-assisted processes to form nitrogen-containing carbon films include a plasma strike on the carbon film after film formation and addition of N2 and NH3 in the gas phase during the film formation process. Such techniques generally result in C—NH2 bond termination and dangling bonds, as verified with FTIR analysis. Although such techniques can work well for some applications, in other applications, it may be desirable to have or to increase an amount of carbon-terminated carbon-nitrogen bonds, such as C—N—C and C—N═C, in nitrogen-containing carbon films. The inclusion of carbon-terminated carbon-nitrogen bonds can improve desired chemical properties (e.g., etch and CMP resistance) and physical properties (e.g., optical) of nitrogen-containing carbon films.


Accordingly, improved methods for forming nitrogen-containing carbon films, particularly for methods of forming nitrogen-containing carbon films that include carbon-terminated carbon-nitrogen bonds, such as C—N—C and C—N═C, are desired.


Any discussion, including discussion of problems and solutions, set forth in this section, has been included in this disclosure solely for the purpose of providing a context for the present disclosure, and should not be taken as an admission that any or all of the discussion was known at the time the invention was made or otherwise constitutes prior art.


SUMMARY OF THE DISCLOSURE

Various embodiments of the present disclosure relate to methods of forming nitrogen-containing carbon films suitable for use in the formation of electronic devices. While the ways in which various embodiments of the present disclosure address drawbacks of prior methods and structures are discussed in more detail below, in general, exemplary embodiments of the disclosure provide improved methods that include improved precursors and techniques for forming nitrogen-containing carbon films.


In accordance with various embodiments of the disclosure, a method of forming a nitrogen-containing carbon film is provided. Exemplary methods can include providing a precursor to a reaction chamber and forming the nitrogen-containing film on a surface of a substrate using the precursor. Suitable precursors include compounds including carbon-terminated carbon-nitrogen bonds, such as one or more compounds (1) represented by (C—N—C)a and/or (C—N═C)a1, wherein a and a1 are integers that are independently selected and that are greater than or equal to 1 and (2) cyclic compounds having a cyclic structure comprising C, H, O, and N. Exemplary cyclic compounds can include a cyclic skeleton, including, for example, between 5 and 7 atoms. The cyclic skeleton can include nitrogen. In some cases, the cyclic skeleton can consist of one or more of C, O, and N, such as C and N or O, C, and N. A cyclic compound can consist of C, H, O, and N. The cyclic compound can include a cyclic skeleton and one or more atoms (e.g., hydrogen and/or oxygen), groups, and/or side chains attached to the cyclic skeleton. At least one of the one or more sidechains can include CwHxNyOz, wherein w, x, y and z are each individually selected and are each a natural number (including zero). Exemplary methods can further include a step of providing a reactant to the reaction chamber. Exemplary reactants include one or more of hydrogen, nitrogen, a compound comprising hydrogen and nitrogen, and a hydrocarbon.


In accordance with yet further exemplary embodiments of the disclosure, a structure is formed, at least in part, by forming a nitrogen-containing carbon film as described herein.


In accordance with yet further exemplary embodiments of the disclosure, a system is provided for performing a method and/or for forming a structure as described herein.


These and other embodiments will become readily apparent to those skilled in the art from the following detailed description of certain embodiments having reference to the attached figures; the invention not being limited to any particular embodiment(s) disclosed.





BRIEF DESCRIPTION OF THE DRAWING FIGURES

A more complete understanding of exemplary embodiments of the present disclosure can be derived by referring to the detailed description and claims when considered in connection with the following illustrative figures.



FIG. 1 illustrates a structure including a nitrogen-containing carbon film in accordance with exemplary embodiments of the disclosure.



FIGS. 2 and 3 illustrate molecules including carbon-terminated carbon-nitrogen bonds.



FIG. 4 illustrates a system in accordance with exemplary embodiments of the disclosure.





It will be appreciated that elements in the figures are illustrated for simplicity and clarity and have not necessarily been drawn to scale. For example, the dimensions of some of the elements in the figures may be exaggerated relative to other elements to help improve understanding of illustrated embodiments of the present disclosure.


DETAILED DESCRIPTION OF EXEMPLARY EMBODIMENTS

Although certain embodiments and examples are disclosed below, it will be understood by those in the art that the invention extends beyond the specifically disclosed embodiments and/or uses of the invention and obvious modifications and equivalents thereof. Thus, it is intended that the scope of the invention disclosed should not be limited by the particular disclosed embodiments described below.


The present disclosure generally relates to methods of forming a nitrogen-containing carbon film, to methods of forming structures including such films, to film structures formed using the methods, and to systems for performing the methods and/or forming the film structures.


Exemplary methods described herein can be used to form nitrogen-containing carbon films with carbon-terminated carbon-nitrogen bonds or form nitrogen-containing carbon films with an increased number of carbon-terminated carbon-nitrogen bonds, particularly C—N—C or C—NC. Such films can exhibit desired properties, such as optical properties, increased (e.g., dry) etch resistance, and/or increased CMP resistance. As set forth in more detail below, films including C—N—C or C—N═C can be obtained by using one or more precursors that include C—N—C or C—N═C bonds.


In this disclosure, “gas” can refer to material that is a gas at normal temperature and pressure, a vaporized solid and/or a vaporized liquid, and may be constituted by a single gas or a mixture of gases, depending on the context. A gas other than a process gas, i.e., a gas introduced without passing through a gas distribution assembly, such as a showerhead, other gas distribution device, or the like, may be used for, e.g., sealing a reaction space, which includes a seal gas, such as a rare gas. In some cases, such as in the context of deposition of material, the term “precursor” can refer to a compound that participates in the chemical reaction that produces another compound, and particularly to a compound that constitutes a film matrix or a main skeleton of a film, whereas the term “reactant” can refer to a compound, in some cases other than a precursor, that activates a precursor, modifies a precursor, or catalyzes a reaction of a precursor; a reactant may provide an element (such as O, H, N, C) to a film matrix and become a part of the film matrix when, for example, power (e.g., radio frequency (RF) or microwave power) is applied. In some cases, the terms precursor and reactant can be used interchangeably. The term “inert gas” refers to a gas that does not take part in a chemical reaction to an appreciable extent and/or a gas that excites a precursor (e.g., to facilitate polymerization of the precursor) when, for example, power (e.g., RF power) is applied, but unlike a reactant, it may not become a part of a film matrix to an appreciable extent.


As used herein, the term “substrate” can refer to any underlying material or materials that may be used to form, or upon which, a device, a circuit, or a film may be formed. A substrate can include a bulk material, such as silicon (e.g., single-crystal silicon), other Group IV materials, such as germanium, or compound semiconductor materials, such as Group III-V or Group II-VI semiconductors, and can include one or more layers overlying or underlying the bulk material. Further, the substrate can include various features, such as gaps (e.g., recesses or vias), lines or protrusions, such as lines having gaps formed therebetween, and the like formed on or within or on at least a portion of a layer or bulk material of the substrate. By way of examples, one or more features can have a width of about 10 nm to about 100 nm, a depth or height of about 30 nm to about 1,000 nm, and/or an aspect ratio of about 3.0 to 100.0.


In some embodiments, “film” refers to a layer extending in a direction perpendicular to a thickness direction. In some embodiments, “layer” refers to a material having a certain thickness formed on a surface and can be a synonym of a film or a non-film structure. A film or layer may be constituted by a discrete single film or layer having certain characteristics or multiple films or layers, and a boundary between adjacent films or layers may or may not be clear and may or may not be established based on physical, chemical, and/or any other characteristics, formation processes or sequence, and/or functions or purposes of the adjacent films or layers. The layer or film can be continuous—or not. Further, a single film or layer can be formed using multiple deposition cycles.


As used herein, the term “nitrogen-containing carbon layer” or “nitrogen-containing carbon material” can refer to a layer whose chemical formula can be represented as including carbon and nitrogen. Layers comprising nitrogen-containing carbon material can include other elements, such as one or more of oxygen and hydrogen. Nitrogen-containing carbon layers desirably include one or more of C—N—C and C—N═C.


As used herein, the term “structure” can refer to a partially or completely fabricated device structure. By way of examples, a structure can be a substrate or include a substrate with one or more layers and/or features formed thereon.


As used herein, the term “cyclic deposition process” can refer to a vapor deposition process in which deposition cycles, typically a plurality of consecutive deposition cycles, are conducted in a process chamber. Cyclic deposition processes can include cyclic chemical vapor deposition (CVD) and atomic layer deposition processes. A cyclic deposition process can include one or more cycles that include plasma activation of a precursor, a reactant, and/or an inert gas.


In this disclosure, “continuously” can refer to without breaking a vacuum, without interruption as a timeline, without any material intervening step, immediately thereafter, as a next step, or without an intervening discrete physical or chemical structure between two structures other than the two structures in some embodiments and depending on the context.


In this disclosure, any two numbers of a variable can constitute a workable range of the variable, and any ranges indicated may include or exclude the endpoints. Additionally, any values of variables indicated (regardless of whether they are indicated with “about” or not) may refer to precise values or approximate values and include equivalents, and may refer to average, median, representative, majority, etc. in some embodiments. Further, in this disclosure, the terms “including,” “constituted by” and “having” can refer independently to “typically or broadly comprising,” “comprising,” “consisting essentially of,” or “consisting of” in some embodiments. In this disclosure, any defined meanings do not necessarily exclude ordinary and customary meanings in some embodiments.



FIG. 1 illustrates a structure 100 including a substrate 102 and a nitrogen-containing film 104 deposited overlying the substrate. In accordance with examples of the disclosure, nitrogen-containing film 104 can be formed using a method as described herein. Additionally or alternatively, nitrogen-containing film 104 can include carbon-terminated carbon-nitrogen bonds. For example, all nitrogen-carbon bonds can be terminated with a carbon-nitrogen bond.


Methods in accordance with exemplary embodiments of the disclosure include providing a precursor to a reaction chamber and forming the nitrogen-containing film on a surface of a substrate using the precursor. The methods can also include steps of providing a substrate to a reaction chamber and, in accordance with some examples, providing a reactant to the reaction chamber. The step of forming can be thermally activated or plasma activated.


During the step of providing a precursor to a reaction chamber, one or more precursors are flowed into a reaction chamber of a gas-phase reactor. In accordance with examples of the disclosure, the reaction chamber can form part of a cyclical deposition reactor, such as an atomic layer deposition (ALD) (e.g., PEALD) reactor or chemical vapor deposition (CVD) (e.g., PECVD) reactor. Various steps of methods described herein can be performed within a single reaction chamber or can be performed in multiple reaction chambers, such as reaction chambers of a cluster tool.


During the step of providing a substrate within a reaction chamber, before the step of providing the precursor to the reaction chamber, or during the step of providing the precursor to the reaction chamber, the substrate can be brought to a desired temperature and/or the reaction chamber can be brought to a desired pressure, such as a temperature and/or pressure suitable for subsequent steps. By way of examples, a temperature (e.g., of a substrate or a substrate support) within a reaction chamber can be less than or equal to 400° C. or between about 550° C. and about 650° C. In accordance with particular examples of the disclosure, the substrate includes one or more features, such as recesses.


In accordance with examples of the disclosure, the precursor includes one or more compounds in which one or more nitrogen atoms are bonded to a carbon atom, wherein the carbon atom is a terminal atom.



FIG. 2 illustrates molecules/compounds (N-methyl methanimine and trimethylamine) that include a carbon-terminated carbon-nitrogen bond. Although such compounds may work well for some applications, gases composed of such molecules can exhibit an unfavorable odor and therefore may desirably be avoided in some applications.



FIG. 3 illustrates exemplary cyclic structures that include cyclic skeletons (e.g., the ring portion of the compound/structure) in accordance with examples of the disclosure. Use of cyclic compounds that include one or more carbon-terminated carbon-nitrogen bonds (e.g., within the skeleton of the molecule) may be desirable over linear or non-cyclic compounds that include carbon-terminated carbon-nitrogen bonds, because the cyclic compounds with the skeleton including the one or more carbon-terminated carbon-nitrogen bonds may not exhibit as offensive of an odor as the linear compounds with the one or more carbon-terminated carbon-nitrogen bonds. In accordance with further examples of the disclosure, the precursor does not include a halogen, such as fluorine (F), chlorine (CI), bromine (Br), iodine (I), or astatine (At).


In accordance with examples of the disclosure, a chemical formula of the precursor comprises one or more of (1) (C—N—C)a and/or (C—N═C)a1, wherein a and a1 are integers that are independently selected and that are greater than or equal to 1 and (2) a cyclic compound, such as a cyclic compound having a cyclic structure comprising C, H, O, and N. A can range from, for example, about 3 to about 6. A1 can range from about 3 to about 6.


In accordance with examples of the disclosure, a cyclic skeleton of a cyclic compound can include between 5 and 7 atoms. The cyclic skeleton can include one or more nitrogen atoms. A nitrogen atom in the cyclic skeleton can form a single bond or a double bond with carbon in the cyclic skeleton. In addition to carbon and/or nitrogen, a cyclic skeleton can include one or more oxygen atoms. In some cases, the cyclic skeleton can consist of one or more of C, O, and N—for example, C and N or C, N and O. In accordance with further examples, the cyclic compound, including the cyclic skeleton, can consist of one or more of C, H, O, and N—e.g., C, H, and N or C, H, N, and O.


A cyclic compound can include one or more atoms, molecules, groups, and/or sidechains attached to the cyclic skeleton. The atoms can include, for example, N, C, O, and H. The molecules or groups can include, for example, methyl groups, ethyl groups, other hydrocarbon groups, hydroxy groups, or the like.


The side chains can include molecules or groups that are represented by the chemical formula CwHxNyOz, wherein w, x, y and z are each individually selected and are each a natural number, and wherein a natural number can be zero. X can range from 0 to 9 or 15, Y can range from 0 to 3 or 6, and Z can range from 0 to 3.


By way of particular examples, the precursor can be selected from one or more of the group consisting of 1,3,5-trimethylhexahydro-1,3,5-triazine; 1,3,5-triazine; 2,4,6-trimethyl-s-triazene; and 1-methyl-2-pyrrolidinone.


The precursor can be a gas, a liquid, or a solid at normal temperature and pressure. In the cases of liquid or solid precursors, the precursor can be heated to a temperature sufficient to form a gas phase of the precursor.


As noted above, methods in accordance with the disclosure can include providing a reactant to the reaction chamber. The reactant can be flowed to the reaction chamber during or overlapping in time with the step of providing a precursor to a reaction chamber. In some cases, the reactant can be pulsed to the reaction chamber. In some cases, the method of forming a nitrogen-containing carbon film includes a cyclic deposition process, where the step of providing a precursor to a reaction and providing a reactant to the reaction chamber can be separated by a purge step. The purge step can include providing a vacuum and/or a purge gas to the reaction chamber.


In accordance with embodiments of the disclosure, a reactant comprises a compound comprising one or more of H, N, and C. In some cases, the compound can consist of one or more of H, N, and C. By way of examples, the reactant can include one or more of hydrogen, nitrogen, a compound comprising hydrogen and nitrogen (e.g., ammonia, hydrazine, or the like), and a hydrocarbon (e.g., comprising only C and H).


In accordance with further examples of the disclosure, although a precursor can include nitrogen, an amount of nitrogen in the nitrogen-containing carbon film can be manipulated by changing a (e.g., volumetric) ratio of a flowrate of the precursor to a flowrate of the reactant.


One or more of the reactant and the precursor can be exposed to a plasma to create an activated species. The plasma can be generated using a direct plasma, as discussed in more detail below, and/or using a remote plasma. In some cases, the reactant can be exposed to a plasma to generate reactant activated species. In some cases, both the precursor and the reactant are exposed to the plasma (e.g., at the same time or during an overlap period). The activated species can be formed using a continuous plasma or a pulsed plasma. In some cases, an inert gas can be continuously flowed to the reaction chamber and activated species can be periodically formed by cycling the power used to form the plasma.


The plasma can be formed using, for example, a capacitively couple plasma (CCP), and inductively coupled plasma (ICP), or a surface plasma, such as a microwave plasma.


A power (e.g., applied to electrodes) to form or maintain the plasma can range from about 50 W to about 600 W. A frequency of the power can range from about 10 kHz to about 100 MHz.



FIG. 4 illustrates a reactor system 400 in accordance with exemplary embodiments of the disclosure. Reactor system 400 can be used to perform one or more steps or sub steps as described herein and/or to form one or more structures or portions thereof as described herein. For example, reactor system 400 can be used to generate a direct plasma for use in methods disclosed herein.


Reactor system 400 includes a pair of electrically conductive flat-plate electrodes 4, 2 in parallel and facing each other in the interior 11 (reaction zone) of a reaction chamber 3. A plasma can be excited within reaction chamber 3 by applying, for example, HRF power (e.g., 13.56 MHz, 27 MHz, microwave frequencies, or the like) from power source 25 to one electrode (e.g., electrode 4) and electrically grounding the other electrode (e.g., electrode 2). A temperature regulator can be provided in a lower stage 2 (the lower electrode), and a temperature of a substrate 1 placed thereon can be kept at a desired temperature. Electrode 4 can serve as a gas distribution device, such as a shower plate. Reactant gas, dilution gas, if any, precursor gas, and/or the like can be introduced into reaction chamber 3 using one or more of a gas line 20, a gas line 21, and a gas line 22, respectively, and through the shower plate 4. Although illustrated with three gas lines, reactor system 400 can include any suitable number of gas lines.


In reaction chamber 3, a circular duct 13 with an exhaust line 7 is provided, through which gas in the interior 11 of the reaction chamber 3 can be exhausted. Additionally, a transfer chamber 5, disposed below the reaction chamber 3, is provided with a seal gas line 24 to introduce seal gas into the interior 11 of the reaction chamber 3 via the interior 16 (transfer zone) of the transfer chamber 5, wherein a separation plate 14 for separating the reaction zone and the transfer zone is provided (a gate valve through which a wafer is transferred into or from the transfer chamber 5 is omitted from this figure). The transfer chamber is also provided with an exhaust line 6. In some embodiments, the deposition and treatment steps are performed in the same reaction space, so that two or more (e.g., all) of the steps can be continuously conducted without exposing the substrate to air or other oxygen-containing atmosphere.


In some embodiments, continuous flow of an inert or carrier gas to reaction chamber 3 can be accomplished using a flow-pass system (FPS), wherein a carrier gas line is provided with a detour line having a precursor reservoir (bottle), and the main line and the detour line are switched, wherein when only a carrier gas is intended to be fed to a reaction chamber, the detour line is closed, whereas when both the carrier gas and a precursor gas are intended to be fed to the reaction chamber, the main line is closed and the carrier gas flows through the detour line and flows out from the bottle together with the precursor gas. In this way, the carrier gas can continuously flow into the reaction chamber and can carry the precursor gas in pulses by switching between the main line and the detour line, without substantially fluctuating pressure of the reaction chamber.


A skilled artisan will appreciate that the apparatus includes one or more controller(s) 26 programmed or otherwise configured to cause one or more method steps as described herein to be conducted. The controller(s) are communicated with the various power sources, heating systems, pumps, robotics and gas flow controllers, or valves of the reactor, as will be appreciated by the skilled artisan.


In some embodiments, a dual chamber reactor (two sections or compartments for processing wafers disposed close to each other) can be used, wherein a reactant gas and a noble gas can be supplied through a shared line, whereas a precursor gas is supplied through unshared lines.


The example embodiments of the disclosure described above do not limit the scope of the invention, since these embodiments are merely examples of the embodiments of the invention. Any equivalent embodiments are intended to be within the scope of this invention. Indeed, various modifications of the disclosure, in addition to those shown and described herein, such as alternative useful combinations of the elements described, may become apparent to those skilled in the art from the description. Such modifications and embodiments are also intended to fall within the scope of the appended claims.

Claims
  • 1. A method of forming a nitrogen-containing carbon film, the method comprising the steps of: providing a precursor to a reaction chamber, wherein a chemical formula of the precursor comprises a cyclic compound having a cyclic structure comprising C, H, and N; andforming the nitrogen-containing film on a surface of a substrate using the precursor, wherein the precursor comprises a carbon-terminated carbon-nitrogen bond and wherein the precursor is selected from one or more of the group consisting of 1,3,5-trimethylhexahydro-1,3,5-triazine, 2,4,6-trimethyl-s-triazene, and 1-methyl-2-pyrrolidinone.
  • 2. The method of claim 1, further comprising a step of providing a reactant to the reaction chamber.
  • 3. The method of claim 2, wherein the reactant comprises a compound comprising C.
  • 4. The method of claim 2, wherein the reactant comprise a hydrocarbon.
  • 5. The method of claim 2, further comprising a step of manipulating an amount of nitrogen in the nitrogen-containing carbon film by changing a ratio of a flowrate of the precursor to a flowrate of the reactant.
  • 6. The method of claim 2, wherein the reactant comprises a compound comprising one or more of H, N, and C.
  • 7. The method of claim 2, wherein the reactant comprises one or more of hydrogen, nitrogen, a compound comprising hydrogen and nitrogen, and a hydrocarbon.
  • 8. The method of claim 1, wherein a temperature of the substrate is between about 550° C. and about 650° C.
  • 9. The method of claim 1, wherein the step of forming the nitrogen-containing carbon film comprises a plasma process.
  • 10. The method of claim 9, wherein the plasma process comprises a direct plasma.
  • 11. The method of claim 9, wherein the plasma process comprises use of one or more of a capacitively-coupled plasma, an inductively-coupled plasma, and a microwave plasma.
  • 12. The method of claim 1, wherein the nitrogen-containing carbon film is deposited using a plasma-enhanced atomic layer deposition process.
  • 13. A method of forming a structure comprising a method of claim 1, wherein the nitrogen-containing carbon film comprises carbon-terminated carbon-nitrogen bonds.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application claims the benefit of and priority to U.S. Provisional Application No. 63/009,318, filed on Apr. 13, 2020 in the United States Patent and Trademark Office, the disclosure of which is incorporated herein in its entirety by reference.

US Referenced Citations (697)
Number Name Date Kind
3197682 Klass et al. Jul 1965 A
3634740 Stevko Jan 1972 A
3916270 Wachtler et al. Oct 1975 A
3983401 Livesay Sep 1976 A
4099041 Berkman et al. Jul 1978 A
4184188 Briglia Jan 1980 A
4241000 McCauley et al. Dec 1980 A
4384918 Abe May 1983 A
4412133 Eckes et al. Oct 1983 A
4480284 Tojo et al. Oct 1984 A
4481300 Hartnett et al. Nov 1984 A
4496828 Kusmierz et al. Jan 1985 A
4502094 Lewin et al. Feb 1985 A
4520116 Gentilman et al. May 1985 A
4520421 Sakitani et al. May 1985 A
4535628 Hope Aug 1985 A
4551192 Di Milia et al. Nov 1985 A
4554611 Lewin Nov 1985 A
4700089 Fujii et al. Oct 1987 A
4720362 Gentilman et al. Jan 1988 A
4804086 Grohrock Feb 1989 A
4880982 Hoksaas Nov 1989 A
4886162 Ambrogio Dec 1989 A
4931135 Horiuchi et al. Jun 1990 A
4949671 Davis et al. Aug 1990 A
4963506 Liaw et al. Oct 1990 A
5117121 Watanabe et al. May 1992 A
5124272 Saito et al. Jun 1992 A
5125710 Gianelo Jun 1992 A
5186120 Ohnishi et al. Feb 1993 A
5208961 Lajoie May 1993 A
5219226 James Jun 1993 A
5231062 Mathers et al. Jul 1993 A
5242501 McDiarmid Sep 1993 A
5250092 Nakano Oct 1993 A
5252133 Miyazaki et al. Oct 1993 A
5252134 Stauffer Oct 1993 A
5280894 Witcraft et al. Jan 1994 A
5295777 Hodos Mar 1994 A
5298089 Bowe et al. Mar 1994 A
5308788 Fitch et al. May 1994 A
5310410 Begin et al. May 1994 A
5328360 Yokokawa Jul 1994 A
5362328 Gardiner et al. Nov 1994 A
5378501 Foster et al. Jan 1995 A
5456757 Aruga et al. Oct 1995 A
5478429 Komino et al. Dec 1995 A
5518780 Tamor et al. May 1996 A
5540821 Tepman Jul 1996 A
5565038 Ashley Oct 1996 A
5584936 Pickering et al. Dec 1996 A
5584963 Takahashi Dec 1996 A
5637153 Niino et al. Jun 1997 A
5645646 Beinglass et al. Jul 1997 A
5661263 Salvaggio Aug 1997 A
5683561 Hollars et al. Nov 1997 A
5690742 Ogata et al. Nov 1997 A
5732957 Yu Mar 1998 A
5804505 Yamada et al. Sep 1998 A
5851293 Lane et al. Dec 1998 A
5855687 DuBois et al. Jan 1999 A
5871586 Crawley et al. Feb 1999 A
5888304 Umotoy et al. Mar 1999 A
5897710 Sato et al. Apr 1999 A
5976973 Ohira et al. Nov 1999 A
6022180 Motoyama et al. Feb 2000 A
6022802 Jang Feb 2000 A
6025117 Nakano et al. Feb 2000 A
6033215 Ohsawa Mar 2000 A
6090442 Klaus et al. Jul 2000 A
6093611 Gardner et al. Jul 2000 A
6099651 Sajoto et al. Aug 2000 A
6139983 Ohashi et al. Oct 2000 A
6143129 Savas et al. Nov 2000 A
6152669 Morita et al. Nov 2000 A
6159301 Sato et al. Dec 2000 A
6176929 Fukunaga et al. Jan 2001 B1
6177688 Linthicum et al. Jan 2001 B1
6189482 Zhao et al. Feb 2001 B1
6217662 Kong et al. Apr 2001 B1
6224679 Sasaki et al. May 2001 B1
6235121 Honma et al. May 2001 B1
6239402 Araki et al. May 2001 B1
6239715 Belton May 2001 B1
6245647 Akiyama et al. Jun 2001 B1
6271320 Keller et al. Aug 2001 B1
6328864 Ishizawa et al. Dec 2001 B1
6335293 Luo et al. Jan 2002 B1
6387823 Sonderman et al. May 2002 B1
6452017 Uhlenbrock et al. Sep 2002 B1
6462310 Ratliff et al. Oct 2002 B1
6464825 Shinozaki Oct 2002 B1
6474987 Huang et al. Nov 2002 B1
6475902 Hausmann et al. Nov 2002 B1
6596398 Russo et al. Jul 2003 B1
6623799 Lee et al. Sep 2003 B1
6658933 Allegre et al. Dec 2003 B2
6659111 Mouri et al. Dec 2003 B1
6676759 Takagi Jan 2004 B1
6692903 Chen et al. Feb 2004 B2
6712949 Gopal Mar 2004 B2
6716477 Komiyama et al. Apr 2004 B1
6720262 Koh et al. Apr 2004 B2
6766545 Hodges Jul 2004 B2
6776849 Aggarwal et al. Aug 2004 B2
6818566 Leeson et al. Nov 2004 B2
6821889 Elers et al. Nov 2004 B2
6825106 Gao et al. Nov 2004 B1
6843858 Rossman Jan 2005 B2
6854580 Braford Feb 2005 B2
6867086 Chen et al. Mar 2005 B1
6867153 Tokunaga Mar 2005 B2
6902647 Hasper Jun 2005 B2
RE38937 Nakamura Jan 2006 E
D524600 Austin et al. Jul 2006 S
D525127 Cogley et al. Jul 2006 S
7122844 Nakamura et al. Oct 2006 B2
7144806 Fair et al. Dec 2006 B1
D535673 Conway et al. Jan 2007 S
7229502 Wang et al. Jun 2007 B2
D549815 Murphy Aug 2007 S
7297641 Todd et al. Nov 2007 B2
7311977 Yokota et al. Dec 2007 B2
D562357 Hardy Feb 2008 S
7410915 Morisada et al. Aug 2008 B2
7504344 Matsuki et al. Mar 2009 B2
7632549 Goundar Dec 2009 B2
7638441 Morisada et al. Dec 2009 B2
7662689 Boyanov et al. Feb 2010 B2
D614258 Kojima Apr 2010 S
7727880 Chattopadhyay et al. Jun 2010 B1
7858898 Bailey et al. Dec 2010 B2
D633452 Namiki et al. Mar 2011 S
8128333 Aburatani Mar 2012 B2
8173554 Lee et al. May 2012 B2
8253204 Lee et al. Aug 2012 B2
8278224 Mui et al. Oct 2012 B1
8318584 Li et al. Nov 2012 B2
8404044 Arai Mar 2013 B2
8435894 Chandrashekar et al. May 2013 B2
8443484 Ozaki et al. May 2013 B2
8507720 Shay Aug 2013 B2
D693782 Mori et al. Nov 2013 S
8637384 Ando et al. Jan 2014 B2
8784676 Guha et al. Jul 2014 B2
8895395 Kerber et al. Nov 2014 B1
8937800 Lubomirsky et al. Jan 2015 B2
8968989 Ouattara et al. Mar 2015 B2
8969934 Cheng et al. Mar 2015 B1
8993072 Xiao et al. Mar 2015 B2
9117657 Nakano et al. Aug 2015 B2
9136108 Matsushita et al. Sep 2015 B2
9171714 Mori et al. Oct 2015 B2
9214340 Kurita et al. Dec 2015 B2
9281223 Hara Mar 2016 B2
9337031 Kim et al. May 2016 B2
D759193 Gutierrez et al. Jun 2016 S
D761325 Abed Jul 2016 S
9428833 Duvall et al. Aug 2016 B1
9449843 Korolik et al. Sep 2016 B1
9449987 Miyata et al. Sep 2016 B1
9455138 Fukazawa et al. Sep 2016 B1
9460954 De Jong et al. Oct 2016 B2
9472410 Sadjadi et al. Oct 2016 B2
9523148 Pore et al. Dec 2016 B1
9605736 Foshage et al. Mar 2017 B1
D784276 Tiner et al. Apr 2017 S
9618846 Shamma et al. Apr 2017 B2
9653267 Carducci et al. May 2017 B2
D793526 Behdjat Aug 2017 S
D794753 Miller Aug 2017 S
9748104 Sasaki et al. Aug 2017 B2
D797067 Zhang et al. Sep 2017 S
D798248 Hanson et al. Sep 2017 S
9754818 Shiu et al. Sep 2017 B2
D800782 Bever et al. Oct 2017 S
9803926 Kikuchi et al. Oct 2017 B2
D801942 Riker et al. Nov 2017 S
D802472 Sasaki et al. Nov 2017 S
D803802 Sasaki et al. Nov 2017 S
9812372 Choi et al. Nov 2017 B2
9824881 Niskanen et al. Nov 2017 B2
9837355 Briggs et al. Dec 2017 B2
9842835 Cheng et al. Dec 2017 B1
9847247 Huang et al. Dec 2017 B2
9850573 Sun Dec 2017 B1
D807494 Kim et al. Jan 2018 S
9911595 Smith et al. Mar 2018 B1
9929055 Dube et al. Mar 2018 B2
9970112 Koshi et al. May 2018 B2
10018920 Chang et al. Jul 2018 B2
D825505 Hanson et al. Aug 2018 S
D825614 Bever et al. Aug 2018 S
10043661 Kato et al. Aug 2018 B2
D829306 Ikedo et al. Sep 2018 S
D834686 Yamada et al. Nov 2018 S
10179947 Fukazawa Jan 2019 B2
10229851 Briggs et al. Mar 2019 B2
10229985 Li et al. Mar 2019 B1
D846008 Geldenhuys et al. Apr 2019 S
D849055 Kneip May 2019 S
10332747 Watanabe et al. Jun 2019 B1
10388513 Blanquart Aug 2019 B1
10395963 Cooke Aug 2019 B2
10424476 Suzuki et al. Sep 2019 B2
10424477 Niskanen et al. Sep 2019 B2
D864134 Watarai et al. Oct 2019 S
10435790 Fukazawa et al. Oct 2019 B2
10510529 Suzuki et al. Dec 2019 B2
10590535 Huggare Mar 2020 B2
D881338 Chen Apr 2020 S
10622236 Kuo et al. Apr 2020 B2
10662525 Jang et al. May 2020 B2
10704143 Hisamitsu et al. Jul 2020 B1
10731249 Hatanpää et al. Aug 2020 B2
10734497 Zhu et al. Aug 2020 B2
10741386 Chen et al. Aug 2020 B2
10770336 Hill et al. Sep 2020 B2
D913980 Lee et al. Mar 2021 S
D914620 Rokkam et al. Mar 2021 S
10950477 Lin et al. Mar 2021 B2
11018003 Huang et al. May 2021 B2
D922229 Jun et al. Jun 2021 S
11053584 Hsieh et al. Jul 2021 B2
20010003271 Otsuki Jun 2001 A1
20010007244 Matsuse Jul 2001 A1
20010019347 Hauck Sep 2001 A1
20010024387 Raaijmakers et al. Sep 2001 A1
20010027585 Lee Oct 2001 A1
20010042514 Mizuno et al. Nov 2001 A1
20010052556 Ting et al. Dec 2001 A1
20010054381 Umotoy et al. Dec 2001 A1
20020015853 Wataya et al. Feb 2002 A1
20020022347 Park et al. Feb 2002 A1
20020033183 Sun et al. Mar 2002 A1
20020036065 Yamagishi et al. Mar 2002 A1
20020047705 Tada et al. Apr 2002 A1
20020052119 Cleemput May 2002 A1
20020061716 Korovin et al. May 2002 A1
20020079056 Kudo et al. Jun 2002 A1
20020106909 Kato et al. Aug 2002 A1
20020108570 Lindfors Aug 2002 A1
20020117262 Pang et al. Aug 2002 A1
20020127956 Ashjaee et al. Sep 2002 A1
20030008602 Ashjaee et al. Jan 2003 A1
20030013314 Ying et al. Jan 2003 A1
20030029563 Kaushal et al. Feb 2003 A1
20030049571 Hallock et al. Mar 2003 A1
20030049580 Goodman Mar 2003 A1
20030056726 Holst et al. Mar 2003 A1
20030075107 Miyano et al. Apr 2003 A1
20030111012 Takeshima Jun 2003 A1
20030113995 Xia et al. Jun 2003 A1
20030132319 Hytros et al. Jul 2003 A1
20030143846 Sekiya et al. Jul 2003 A1
20030150386 Shimada Aug 2003 A1
20030157345 Beldi et al. Aug 2003 A1
20030168174 Foree Sep 2003 A1
20030181065 O'Donnell Sep 2003 A1
20030200926 Dando et al. Oct 2003 A1
20030205237 Sakuma Nov 2003 A1
20030232497 Xi et al. Dec 2003 A1
20040005753 Kostamo et al. Jan 2004 A1
20040018694 Lee et al. Jan 2004 A1
20040058517 Nallan et al. Mar 2004 A1
20040082171 Shin et al. Apr 2004 A1
20040083962 Bang et al. May 2004 A1
20040099635 Nishikawa May 2004 A1
20040104439 Haukka et al. Jun 2004 A1
20040112288 Whitesell Jun 2004 A1
20040118342 Cheng et al. Jun 2004 A1
20040126929 Tang et al. Jul 2004 A1
20040154746 Park Aug 2004 A1
20040163590 Tran et al. Aug 2004 A1
20040224478 Chudzik et al. Nov 2004 A1
20040226507 Carpenter et al. Nov 2004 A1
20040241341 Lin Dec 2004 A1
20040253790 Ootsuka Dec 2004 A1
20040261706 Lindfors et al. Dec 2004 A1
20050006682 Bae et al. Jan 2005 A1
20050016452 Ryu et al. Jan 2005 A1
20050023231 Huang et al. Feb 2005 A1
20050051854 Cabral et al. Mar 2005 A1
20050062773 Fouet Mar 2005 A1
20050074576 Chaiken et al. Apr 2005 A1
20050081786 Kubista et al. Apr 2005 A1
20050085090 Mui et al. Apr 2005 A1
20050090123 Nishimura et al. Apr 2005 A1
20050092439 Keeton et al. May 2005 A1
20050101154 Huang May 2005 A1
20050104112 Haukka et al. May 2005 A1
20050133166 Satitpunwaycha et al. Jun 2005 A1
20050136657 Yokoi et al. Jun 2005 A1
20050142361 Nakanishi et al. Jun 2005 A1
20050153573 Okudaira et al. Jul 2005 A1
20050164469 Haupt Jul 2005 A1
20050170306 Oosterlaken et al. Aug 2005 A1
20050193952 Goodman et al. Sep 2005 A1
20050285208 Ren et al. Dec 2005 A1
20060008997 Jang et al. Jan 2006 A1
20060019495 Marcadal et al. Jan 2006 A1
20060057858 Chung et al. Mar 2006 A1
20060097220 Kim et al. May 2006 A1
20060097305 Lee May 2006 A1
20060110930 Senzaki May 2006 A1
20060115589 Vukovic Jun 2006 A1
20060118241 Ohmi et al. Jun 2006 A1
20060130751 Volfovski et al. Jun 2006 A1
20060133955 Peters Jun 2006 A1
20060141758 Naumann et al. Jun 2006 A1
20060148151 Murthy et al. Jul 2006 A1
20060156979 Thakur et al. Jul 2006 A1
20060162661 Jung et al. Jul 2006 A1
20060176928 Nakamura et al. Aug 2006 A1
20060193980 Hasegawa Aug 2006 A1
20060211224 Matsuda Sep 2006 A1
20060213441 Kobrin et al. Sep 2006 A1
20060223337 Ahn et al. Oct 2006 A1
20060249175 Nowak et al. Nov 2006 A1
20060252244 Vaartstra et al. Nov 2006 A1
20070026654 Huotari et al. Feb 2007 A1
20070065597 Kaido et al. Mar 2007 A1
20070087515 Yieh et al. Apr 2007 A1
20070092696 Tsukatani et al. Apr 2007 A1
20070111030 Nakano et al. May 2007 A1
20070123060 Rahtu May 2007 A1
20070128570 Goto et al. Jun 2007 A1
20070134821 Thakur et al. Jun 2007 A1
20070144442 Migita Jun 2007 A1
20070163490 Habel et al. Jul 2007 A1
20070166459 Chang et al. Jul 2007 A1
20070205788 Natsuhara et al. Sep 2007 A1
20070215278 Furuse et al. Sep 2007 A1
20070222131 Fukumoto et al. Sep 2007 A1
20070248832 Maeda et al. Oct 2007 A1
20070264427 Shinriki et al. Nov 2007 A1
20070264793 Oh et al. Nov 2007 A1
20070281106 Lubomirsky et al. Dec 2007 A1
20080032514 Sano et al. Feb 2008 A1
20080044932 Samoilov et al. Feb 2008 A1
20080069951 Chacin et al. Mar 2008 A1
20080092821 Otsuka et al. Apr 2008 A1
20080110401 Fujikawa et al. May 2008 A1
20080110568 Son et al. May 2008 A1
20080135516 Yokogawa et al. Jun 2008 A1
20080135936 Nakajima Jun 2008 A1
20080142046 Johnson et al. Jun 2008 A1
20080157212 Lavoie et al. Jul 2008 A1
20080194088 Srinivasan et al. Aug 2008 A1
20080194113 Kim et al. Aug 2008 A1
20080210162 Yonebayashi Sep 2008 A1
20080223725 Han et al. Sep 2008 A1
20080229811 Zhao et al. Sep 2008 A1
20080230352 Hirata Sep 2008 A1
20080237604 Alshareef et al. Oct 2008 A1
20080246101 Li et al. Oct 2008 A1
20080276864 Koelmel et al. Nov 2008 A1
20080293198 Kojima et al. Nov 2008 A1
20090031954 Nishikido et al. Feb 2009 A1
20090035463 Dip Feb 2009 A1
20090035946 Pierreux et al. Feb 2009 A1
20090060480 Herchen Mar 2009 A1
20090080136 Nagayama et al. Mar 2009 A1
20090093100 Xia et al. Apr 2009 A1
20090117723 Kim et al. May 2009 A1
20090176018 Zou et al. Jul 2009 A1
20090236315 Willwerth et al. Sep 2009 A1
20090291566 Ueno et al. Nov 2009 A1
20090297696 Pore et al. Dec 2009 A1
20090297731 Goundar Dec 2009 A1
20090314309 Sankarakrishnan et al. Dec 2009 A1
20100008656 Sorabji et al. Jan 2010 A1
20100012153 Shigemoto et al. Jan 2010 A1
20100031884 Aggarwal et al. Feb 2010 A1
20100038687 Klaus et al. Feb 2010 A1
20100075488 Collins et al. Mar 2010 A1
20100116208 Sangam May 2010 A1
20100119844 Sun et al. May 2010 A1
20100121100 Shay May 2010 A1
20100129670 Sun et al. May 2010 A1
20100133255 Bahng et al. Jun 2010 A1
20100147396 Yamagishi et al. Jun 2010 A1
20100163187 Yokogawa et al. Jul 2010 A1
20100178423 Shimizu et al. Jul 2010 A1
20100195690 Moench et al. Aug 2010 A1
20100258809 Muller Oct 2010 A1
20100322822 Fritchie et al. Dec 2010 A1
20110089419 Yamazaki et al. Apr 2011 A1
20110091650 Noguchi et al. Apr 2011 A1
20110100489 Orito et al. May 2011 A1
20110117728 Su et al. May 2011 A1
20110127702 Gautam et al. Jun 2011 A1
20110171380 Higashi et al. Jul 2011 A1
20110186984 Saito et al. Aug 2011 A1
20110195574 Blasco et al. Aug 2011 A1
20110212625 Toyoda et al. Sep 2011 A1
20110237082 Nakajima et al. Sep 2011 A1
20110254138 Babich Oct 2011 A1
20110256692 Tam et al. Oct 2011 A1
20110286819 Shibata et al. Nov 2011 A1
20110297088 Song et al. Dec 2011 A1
20110305856 Bonn Dec 2011 A1
20110318142 Gage et al. Dec 2011 A1
20120003599 Patalay et al. Jan 2012 A1
20120027547 Jager et al. Feb 2012 A1
20120055401 Tozawa Mar 2012 A1
20120077350 Miya et al. Mar 2012 A1
20120088369 Weidman et al. Apr 2012 A1
20120094010 Sugiura et al. Apr 2012 A1
20120108039 Zojaji et al. May 2012 A1
20120111271 Begarney et al. May 2012 A1
20120177845 Odedra et al. Jul 2012 A1
20120187375 Guo et al. Jul 2012 A1
20120196242 Volfovski et al. Aug 2012 A1
20120219735 Bakker et al. Aug 2012 A1
20120222813 Pal et al. Sep 2012 A1
20120231611 Gatineau et al. Sep 2012 A1
20120263875 Brenninger et al. Oct 2012 A1
20120269962 Blomberg et al. Oct 2012 A1
20120270384 Sanchez et al. Oct 2012 A1
20120270407 Werner et al. Oct 2012 A1
20120276306 Ueda Nov 2012 A1
20120320491 Doh et al. Dec 2012 A1
20120329208 Pore et al. Dec 2012 A1
20130011630 Sullivan et al. Jan 2013 A1
20130012003 Haukka et al. Jan 2013 A1
20130017503 De Ridder et al. Jan 2013 A1
20130037532 Volfovski et al. Feb 2013 A1
20130059415 Kato et al. Mar 2013 A1
20130062839 Tschinderle et al. Mar 2013 A1
20130068391 Mazzocco et al. Mar 2013 A1
20130075788 Tomabechi Mar 2013 A1
20130085618 Ding Apr 2013 A1
20130089988 Wang et al. Apr 2013 A1
20130109172 Collins et al. May 2013 A1
20130109192 Hawkins et al. May 2013 A1
20130147050 Bonner, III et al. Jun 2013 A1
20130149874 Hirose et al. Jun 2013 A1
20130162142 Nishino et al. Jun 2013 A1
20130203258 Chen et al. Aug 2013 A1
20130206066 Han et al. Aug 2013 A1
20130213300 Sung et al. Aug 2013 A1
20130216710 Masuda et al. Aug 2013 A1
20130220550 Koo et al. Aug 2013 A1
20130230987 Draeger et al. Sep 2013 A1
20130247937 Nunomura et al. Sep 2013 A1
20130270600 Helander et al. Oct 2013 A1
20130273330 Wang et al. Oct 2013 A1
20140024223 Kilpi et al. Jan 2014 A1
20140057187 Suzuki et al. Feb 2014 A1
20140080314 Sasajima et al. Mar 2014 A1
20140120312 He et al. May 2014 A1
20140127422 Shao et al. May 2014 A1
20140158154 Kondo et al. Jun 2014 A1
20140170320 Yamamoto et al. Jun 2014 A1
20140179092 Kim Jun 2014 A1
20140187022 Falster et al. Jul 2014 A1
20140190581 Nagase et al. Jul 2014 A1
20140242808 Akiyama et al. Aug 2014 A1
20140252710 Cuvalci et al. Sep 2014 A1
20140256160 Wada et al. Sep 2014 A1
20140271081 Lavitsky et al. Sep 2014 A1
20140290573 Okabe et al. Oct 2014 A1
20140327117 Bencher et al. Nov 2014 A1
20140346600 Cheng et al. Nov 2014 A1
20140360430 Armour et al. Dec 2014 A1
20150004806 Ndiege et al. Jan 2015 A1
20150024567 Tsai et al. Jan 2015 A1
20150030782 Ivanov et al. Jan 2015 A1
20150061078 Abel et al. Mar 2015 A1
20150069354 Helander et al. Mar 2015 A1
20150104575 Takoudis et al. Apr 2015 A1
20150110968 Lavoie et al. Apr 2015 A1
20150126036 Zhao May 2015 A1
20150132953 Nowling et al. May 2015 A1
20150137315 Chen et al. May 2015 A1
20150155140 Lee et al. Jun 2015 A1
20150155370 Tsai et al. Jun 2015 A1
20150170907 Haukka et al. Jun 2015 A1
20150176124 Greer et al. Jun 2015 A1
20150247259 Hekmatshoar-Tabari et al. Sep 2015 A1
20150249013 Arghavani et al. Sep 2015 A1
20150267299 Hawkins et al. Sep 2015 A1
20150275355 Mallikarjunan et al. Oct 2015 A1
20150307989 Lindfors Oct 2015 A1
20150311043 Sun et al. Oct 2015 A1
20150340266 Ngo et al. Nov 2015 A1
20160005596 Behera Jan 2016 A1
20160010208 Huang et al. Jan 2016 A1
20160032453 Qian et al. Feb 2016 A1
20160035542 Hausmann Feb 2016 A1
20160086811 Mackedanz et al. Mar 2016 A1
20160101979 Hocke Apr 2016 A1
20160111304 Takahashi et al. Apr 2016 A1
20160133504 Chu et al. May 2016 A1
20160152649 Gordon Jun 2016 A1
20160168704 Choi et al. Jun 2016 A1
20160169766 Ishibashi et al. Jun 2016 A1
20160204005 Oki et al. Jul 2016 A1
20160204436 Barker et al. Jul 2016 A1
20160211166 Yan et al. Jul 2016 A1
20160215387 Liu et al. Jul 2016 A1
20160225588 Shaikh et al. Aug 2016 A1
20160237559 Tsuji Aug 2016 A1
20160273095 Lin et al. Sep 2016 A1
20160273128 Kang Sep 2016 A1
20160279629 Michishita et al. Sep 2016 A1
20160293609 Jha et al. Oct 2016 A1
20160307740 Kim et al. Oct 2016 A1
20160314960 Cheng et al. Oct 2016 A1
20160343612 Wang et al. Nov 2016 A1
20160376701 Takewaki et al. Dec 2016 A1
20170022612 Lei et al. Jan 2017 A1
20170040146 Huang et al. Feb 2017 A1
20170040198 Lin et al. Feb 2017 A1
20170062224 Fu et al. Mar 2017 A1
20170102612 Meyers et al. Apr 2017 A1
20170140924 Suzuki et al. May 2017 A1
20170167023 Proia et al. Jun 2017 A1
20170178939 Omori Jun 2017 A1
20170178942 Sakata et al. Jun 2017 A1
20170191685 Ronne et al. Jul 2017 A1
20170213960 de Araujo et al. Jul 2017 A1
20170218515 Shin et al. Aug 2017 A1
20170222008 Hsu et al. Aug 2017 A1
20170253968 Yahata Sep 2017 A1
20170256393 Kim et al. Sep 2017 A1
20170263438 Li et al. Sep 2017 A1
20170271143 Fukiage et al. Sep 2017 A1
20170283312 Lee et al. Oct 2017 A1
20170283313 Lee et al. Oct 2017 A1
20170306494 Lin et al. Oct 2017 A1
20170314125 Fenwick et al. Nov 2017 A1
20170369993 Sun Dec 2017 A1
20180047621 Armini Feb 2018 A1
20180094350 Verghese et al. Apr 2018 A1
20180096821 Lubomirsky Apr 2018 A1
20180096844 Dutartre et al. Apr 2018 A1
20180105701 Larsson et al. Apr 2018 A1
20180119283 Fukazawa et al. May 2018 A1
20180171472 Yamada et al. Jun 2018 A1
20180209042 Wu et al. Jul 2018 A1
20180265294 Hayashi Sep 2018 A1
20180265972 Firouzdor et al. Sep 2018 A1
20180265973 Firouzdor et al. Sep 2018 A1
20180274098 Takagi et al. Sep 2018 A1
20180315597 Varadarajan et al. Nov 2018 A1
20180327892 Wu et al. Nov 2018 A1
20180327898 Wu et al. Nov 2018 A1
20180327899 Wu et al. Nov 2018 A1
20190019714 Kosakai et al. Jan 2019 A1
20190035698 Tanaka Jan 2019 A1
20190078206 Wu et al. Mar 2019 A1
20190109043 Wang et al. Apr 2019 A1
20190115451 Lee et al. Apr 2019 A1
20190148177 Yin et al. May 2019 A1
20190148556 Wang et al. May 2019 A1
20190172701 Jia et al. Jun 2019 A1
20190172714 Bobek et al. Jun 2019 A1
20190176435 Bellman et al. Jun 2019 A1
20190198297 Aramaki et al. Jun 2019 A1
20190211450 Adachi et al. Jul 2019 A1
20190233446 MacDonald et al. Aug 2019 A1
20190318910 Mori Oct 2019 A1
20190319100 Chen et al. Oct 2019 A1
20190362970 Wang et al. Nov 2019 A1
20190362989 Reuter et al. Nov 2019 A1
20190363015 Cheng et al. Nov 2019 A1
20190378711 Suzuki et al. Dec 2019 A1
20190393304 Guillorn et al. Dec 2019 A1
20200012081 Komai Jan 2020 A1
20200035489 Huang et al. Jan 2020 A1
20200052089 Yu et al. Feb 2020 A1
20200058469 Ranjan et al. Feb 2020 A1
20200066512 Tois et al. Feb 2020 A1
20200105895 Tang et al. Apr 2020 A1
20200119038 Hopkins et al. Apr 2020 A1
20200135915 Savant et al. Apr 2020 A1
20200185249 Rice et al. Jun 2020 A1
20200185257 Nishiwaki Jun 2020 A1
20200203157 Su Jun 2020 A1
20200273728 Benjaminson et al. Aug 2020 A1
20200283894 Lehn et al. Sep 2020 A1
20200312681 Tanaka et al. Oct 2020 A1
20200373152 Blanquart Nov 2020 A1
20200395199 Miyama Dec 2020 A1
20200402846 Collins et al. Dec 2020 A1
20210013034 Wu et al. Jan 2021 A1
20210032754 White et al. Feb 2021 A1
20210033977 Raaijmakers et al. Feb 2021 A1
20210054500 Zope et al. Feb 2021 A1
20210054504 Wang et al. Feb 2021 A1
20210057214 Kengoyama et al. Feb 2021 A1
20210057223 Stevens et al. Feb 2021 A1
20210057275 Pierreux et al. Feb 2021 A1
20210057570 Lin et al. Feb 2021 A1
20210066075 Zhang et al. Mar 2021 A1
20210066079 Lima et al. Mar 2021 A1
20210066080 Mattinen et al. Mar 2021 A1
20210066083 Haukka Mar 2021 A1
20210066084 Raisanen et al. Mar 2021 A1
20210070783 Odedra et al. Mar 2021 A1
20210071296 Watarai et al. Mar 2021 A1
20210071298 Maes et al. Mar 2021 A1
20210074527 Lee et al. Mar 2021 A1
20210082692 Kikuchi Mar 2021 A1
20210090878 Kang et al. Mar 2021 A1
20210095372 Minjauw et al. Apr 2021 A1
20210102289 Tsuji et al. Apr 2021 A1
20210102290 Acosta et al. Apr 2021 A1
20210102292 Lin et al. Apr 2021 A1
20210104384 Parkhe Apr 2021 A1
20210104399 Kuroda et al. Apr 2021 A1
20210108328 Yanagisawa Apr 2021 A1
20210111025 Zyulkov et al. Apr 2021 A1
20210111053 De Ridder Apr 2021 A1
20210118667 Fukazawa et al. Apr 2021 A1
20210118679 Lima et al. Apr 2021 A1
20210118687 Wang et al. Apr 2021 A1
20210125827 Khazaka et al. Apr 2021 A1
20210125832 Bhatnagar Apr 2021 A1
20210134588 Kohen et al. May 2021 A1
20210134959 Lima et al. May 2021 A1
20210140043 Thombare et al. May 2021 A1
20210143003 Fukuda et al. May 2021 A1
20210151315 Pierreux et al. May 2021 A1
20210151348 Utsuno et al. May 2021 A1
20210151352 Zope et al. May 2021 A1
20210156024 Roh et al. May 2021 A1
20210156030 Shugrue May 2021 A1
20210159077 Longrie et al. May 2021 A1
20210166910 Kim et al. Jun 2021 A1
20210166924 Moon et al. Jun 2021 A1
20210166925 Moon et al. Jun 2021 A1
20210166940 Nozawa Jun 2021 A1
20210172064 Moon Jun 2021 A1
20210175052 Takahashi et al. Jun 2021 A1
20210180184 Verni et al. Jun 2021 A1
20210180188 Kim et al. Jun 2021 A1
20210180189 Shugrue et al. Jun 2021 A1
20210184111 Chiang Jun 2021 A1
20210193458 Salmi et al. Jun 2021 A1
20210205758 Kimtee et al. Jul 2021 A1
20210207269 Huang et al. Jul 2021 A1
20210207270 de Ridder et al. Jul 2021 A1
20210210373 Singu et al. Jul 2021 A1
20210214842 Yoon et al. Jul 2021 A1
20210225615 Yoshida Jul 2021 A1
20210225622 Shoji Jul 2021 A1
20210225642 Utsuno et al. Jul 2021 A1
20210225643 Kuroda et al. Jul 2021 A1
20210230744 Kimtee et al. Jul 2021 A1
20210230746 Shiba Jul 2021 A1
20210233772 Zhu et al. Jul 2021 A1
20210238736 Butail et al. Aug 2021 A1
20210238742 Susa et al. Aug 2021 A1
20210239614 Muralidhar et al. Aug 2021 A1
20210242011 Shero et al. Aug 2021 A1
20210246556 Mori Aug 2021 A1
20210247693 Maes et al. Aug 2021 A1
20210249303 Blanquart Aug 2021 A1
20210254216 Mori et al. Aug 2021 A1
20210254238 Khazaka et al. Aug 2021 A1
20210257213 Kikuchi et al. Aug 2021 A1
20210257509 Nishiwaki Aug 2021 A1
20210265134 Singh et al. Aug 2021 A1
20210265158 Kaneko Aug 2021 A1
20210268554 Mori Sep 2021 A1
20210269914 Väyrynen et al. Sep 2021 A1
20210272821 Oosterlaken Sep 2021 A1
20210273109 Yamazaki et al. Sep 2021 A1
20210280448 Ganguli et al. Sep 2021 A1
20210285102 Yoon et al. Sep 2021 A1
20210287878 Um et al. Sep 2021 A1
20210287912 Shiba et al. Sep 2021 A1
20210287928 Kim et al. Sep 2021 A1
20210288476 Wei Sep 2021 A1
20210292902 Kajbafvala et al. Sep 2021 A1
20210296130 Longrie et al. Sep 2021 A1
20210296144 Lin et al. Sep 2021 A1
20210310125 Ma et al. Oct 2021 A1
20210313150 Kang et al. Oct 2021 A1
20210313167 Pore et al. Oct 2021 A1
20210313170 Suzuki Oct 2021 A1
20210313178 Nakano Oct 2021 A1
20210313182 Zhu et al. Oct 2021 A1
20210317576 Väyrynen et al. Oct 2021 A1
20210319982 Kim et al. Oct 2021 A1
20210320003 Sugiura et al. Oct 2021 A1
20210320010 Wang et al. Oct 2021 A1
20210320020 Oosterlaken et al. Oct 2021 A1
20210324510 Kuwano et al. Oct 2021 A1
20210324518 de Ridder Oct 2021 A1
20210327704 Kajbafvala et al. Oct 2021 A1
20210327714 Lee et al. Oct 2021 A1
20210327715 Xie et al. Oct 2021 A1
20210328036 Li et al. Oct 2021 A1
Foreign Referenced Citations (62)
Number Date Country
101047143 Oct 2007 CN
101308794 Sep 2010 CN
102094183 Jun 2011 CN
102539019 Sep 2013 CN
203721699 Jul 2014 CN
104307264 Jan 2015 CN
104498895 Apr 2015 CN
104517892 Apr 2015 CN
204629865 Sep 2015 CN
205448240 Aug 2016 CN
104342637 Feb 2017 CN
206145834 May 2017 CN
104233226 Jun 2017 CN
106895521 Jun 2017 CN
104630735 Dec 2017 CN
107675144 Feb 2018 CN
106011785 Oct 2018 CN
108910843 Nov 2018 CN
109000352 Dec 2018 CN
109573996 Apr 2019 CN
0634785 Jan 1995 EP
2708624 Feb 1995 FR
400010 Oct 1933 GB
1488948 Oct 1977 GB
2051875 Jan 1981 GB
S5979545 May 1984 JP
S59127847 Jul 1984 JP
S60110133 Jun 1985 JP
H0165766 Jun 1989 JP
H01185176 Jul 1989 JP
H01313954 Dec 1989 JP
H03211753 Sep 1991 JP
2002019009 Jan 2002 JP
2002118066 Apr 2002 JP
2004088077 Mar 2004 JP
2004244298 Sep 2004 JP
2005033221 Sep 2004 JP
2006124831 May 2006 JP
2015021175 Feb 2015 JP
2017220011 Dec 2017 JP
20000000946 Jan 2000 KR
100273261 Dec 2000 KR
20070041701 Apr 2007 KR
10-2007-0117817 Dec 2007 KR
10-2010-0015073 Feb 2010 KR
10-2010-0122701 Nov 2010 KR
10-2011-0058534 Jun 2011 KR
10-2013-0129149 Nov 2013 KR
101758892 Jul 2017 KR
201213596 Apr 2012 TW
201234453 Aug 2012 TW
201531587 Aug 2015 TW
2004007800 Jan 2004 WO
2007088940 Aug 2007 WO
2013177269 Nov 2013 WO
2015127614 Sep 2015 WO
2016019795 Feb 2016 WO
2017125401 Jul 2017 WO
2019142055 Jul 2019 WO
2019214578 Nov 2019 WO
2020118100 Jun 2020 WO
2021072042 Apr 2021 WO
Non-Patent Literature Citations (413)
Entry
Gordon, “Chemist's Companion—A Handbook of Practical Data, Techniques, and References” 1972, p. 1-2 (Year: 1972).
Mattox, “Handbook of Physical Vapor Deposition (PVD) Processing—5.5.16 Helicon Plasma Source” 2010, p. 157-193 (Year: 2010).
JP-2002019009-A, machine translation, originally published 2002, p. 1-11 (Year: 2002).
CN-109573996-A, machine translation, originally published 2019, p. 1-14 (Year: 2019).
Wang, J., et al., “Deposition of carbon nitride film from single-source s-triazine precursors”, 2003, Carbon, 41, p. 2031-2037 (Year: 2003).
CNIPA; Office Action dated Mar. 30, 2021 in Application No. 201610131743.1.
CNIPA; Office Action dated Mar. 1, 2021 in Application No. 201710131319.1.
CNIPA; Notice of Allowance dated Mar. 30, 2021 in Application No. 201710762817.6.
CNIPA; Office Action dated Jan. 28, 2021 in Application No. 201711057557.9.
CNIPA; Office Action dated Jan. 26, 2021 in Application No. 201711057929.8.
CNIPA; Office Action dated Apr. 19, 2021 in Application No. 201711328250.8.
CNIPA; Notice of Allowance dated Apr. 7, 2021 in Application No. 201780044761.9.
CNIPA; Office Action dated Jan. 29, 2021 in Application No. 201780076230.8.
CNIPA; Office Action dated Jan. 27, 2021 in Application No. 201780076321.1.
CNIPA; Office Action dated Mar. 24, 2021 in Application No. 201880048547.5.
CNIPA; Office Action dated Dec. 22, 2020 in Application No. 201910378791.4.
CNIPA; Notice of Allowance dated Apr. 7, 2021 in Application No. 202030579755.8.
EPO; Extended European Search Report dated Apr. 6, 2021 in Application No. 21150514.4.
JPO; Notice of Allowance dated Apr. 6, 2021 in Application No. 2017-139817.
JPO; Office Action dated Mar. 31, 2021 in Application No. 2018-024655.
JPO; Notice of Allowance dated Mar. 17, 2021 in Application No. 2020-010953.
KIPO; Office Action dated Mar. 23, 2021 in Application No. 10-2014-0011765.
KIPO; Office Action dated Apr. 27, 2021 in Application No. 10-2014-0027217.
KIPO; Notice of Allowance dated Apr. 15, 2021 in Application No. 10-2014-0103853.
KIPO; Notice of Allowance dated Mar. 25, 2021 in Application No. 10-2014-0128626.
KIPO; Office Action dated Apr. 20, 2021 in Application No. 10-2014-0136089.
KIPO; Office Action dated Mar. 19, 2021 in Application No. 10-2014-0156196.
KIPO; Office Action dated Mar. 29, 2021 in Application No. 10-2014-0165685.
KIPO; Office Action dated Apr. 5, 2021 in Application No. 10-2015-0031720.
KIPO; Office Action dated Apr. 19, 2021 in Application No. 10-2015-0035094.
KIPO; Office Action dated Mar. 8, 2021 in Application No. 10-2017-0054647.
KIPO; Office Action dated Mar. 10, 2021 in Application No. 10-2017-0055703.
KIPO; Notice of Allowance dated May 24, 2021 in Application No. 10-2020-0101096.
KIPO; Notice of Allowance dated Apr. 1, 2021 in Application No. 30-2020-0030139 (M001).
KIPO; Notice of Allowance dated Apr. 1, 2021 in Application No. 30-2020-0030139 (M002).
TIPO; Notice of Allowance dated May 13, 2021 in Application No. 105122394.
TIPO; Notice of Allowance dated Mar. 5, 2021 in Application No. 105131284.
TIPO; Office Action dated Feb. 25, 2021 in Application No. 105134275.
TIPO; Notice of Allowance dated Mar. 4, 2021 in Application No. 106100823.
TIPO; Notice of Allowance dated May 6, 2021 in Application No. 106108522.
TIPO; Notice of Allowance dated Mar. 4, 2021 in Application No. 106111693.
TIPO; Office Action dated Feb. 25, 2021 in Application No. 106121797.
TIPO; Office Action dated Apr. 26, 2021 in Application No. 106122231.
TIPO; Office Action dated Apr. 22, 2021 in Application No. 106124126.
TIPO; Office Action dated Apr. 22, 2021 in Application No. 106124128.
TIPO; Notice of Allowance dated Mar. 25, 2021 in Application No. 106124130.
TIPO; Office Action dated Mar. 4, 2021 in Application No. 106127948.
TIPO; Office Action dated Mar. 15, 2021 in Application No. 106129971.
TIPO; Office Action dated Apr. 7, 2021 in Application No. 106135925.
TIPO; Office Action dated Apr. 7, 2021 in Application No. 106136905.
TIPO; Office Action dated Mar. 29, 2021 in Application No. 106143559.
TIPO; Office Action dated Mar. 31, 2021 in Application No. 106143570.
TIPO; Office Action dated Jan. 15, 2021 in Application No. 108142842.
TIPO; Office Action dated Jan. 25, 2021 in Application No. 108143562.
TIPO; Notice of Allowance dated May 18, 2021 in Application No. 109300595.
TIPO; Notice of Allowance dated Mar. 30, 2021 in Application No. 109305460.
USPTO; Notice of Allowance dated Feb. 10, 2021 in U.S. Appl. No. 14/219,839.
USPTO; Advisory Action dated Apr. 13, 2021 in U.S. Appl. No. 14/829,565.
USPTO; Non-Final Office Action dated May 12, 2021 in U.S. Appl. No. 14/829,565.
USPTO; Final Office Action dated Feb. 24, 2021 in U.S. Appl. No. 15/262,990.
USPTO; Advisory Action dated Apr. 28, 2021 in U.S. Appl. No. 15/262,990.
USPTO; Final Office Action dated Mar. 25, 2021 in U.S. Appl. No. 15/286,503.
USPTO; Advisory Action dated Apr. 30, 2021 in U.S. Appl. No. 15/377,439.
USPTO; Final Office Action dated Jan. 7, 2021 in U.S. Appl. No. 15/380,909.
USPTO; Non-Final Office Action dated Feb. 9, 2021 in U.S. Appl. No. 15/402,993.
USPTO; Final Office Action dated May 21, 2021 in U.S. Appl. No. 15/402,993.
USPTO; Final Office Action dated Jun. 2, 2021 in U.S. Appl. No. 15/611,707.
USPTO; Advisory Action dated Mar. 25, 2021 in U.S. Appl. No. 15/636,307.
USPTO; Non-Final Office Action dated Apr. 21, 2021 in U.S. Appl. No. 15/636,307.
USPTO; Final Office Action dated Mar. 10, 2021 in U.S. Appl. No. 15/690,017.
USPTO; Notice of Allowance dated Apr. 16, 2021 in U.S. Appl. No. 15/691,241.
USPTO; Non-Final Office Action dated Mar. 18, 2021 in U.S. Appl. No. 15/835,328.
USPTO; Notice of Allowance dated Mar. 19, 2021 in U.S. Appl. No. 15/890,037.
USPTO; Final Office Action dated Apr. 19, 2021 in U.S. Appl. No. 15/909,705.
USPTO; Non-Final Office Action dated May 20, 2021 in U.S. Appl. No. 15/917,224.
USPTO; Non-Final Office Action dated Feb. 18, 2021 in U.S. Appl. No. 15/923,834.
USPTO; Advisory Action dated Apr. 28, 2021 in U.S. Appl. No. 15/940,729.
USPTO; Notice of Allowance dated Apr. 7, 2021 in U.S. Appl. No. 15/940,759.
USPTO; Advisory Action dated Feb. 22, 2021 in U.S. Appl. No. 15/962,980.
USPTO; Final Office Action dated Apr. 13, 2021 in U.S. Appl. No. 15/967,146.
USPTO; Advisory Action dated Jun. 2, 2021 in U.S. Appl. No. 15/967,146.
USPTO; Non-Final Office Action dated Feb. 19, 2021 in U.S. Appl. No. 15/974,948.
USPTO; Non-Final Office Action dated May 25, 2021 in U.S. Appl. No. 15/985,539.
USPTO; Non-Final Office Action dated Apr. 5, 2021 in U.S. Appl. No. 15/996,286.
USPTO; Non-Final Office Action dated Feb. 4, 2021 in U.S. Appl. No. 16/000,109.
USPTO; Non-Final Office Action dated May 19, 2021 in U.S. Appl. No. 16/000,125.
USPTO; Notice of Allowance dated Feb. 5, 2021 in U.S. Appl. No. 16/000,156.
USPTO; Non-Final Office Action dated Mar. 19, 2021 in U.S. Appl. No. 16/004,041.
USPTO; Final Office Action dated Mar. 23, 2021 in U.S. Appl. No. 16/039,817.
USPTO; Advisory Action dated May 28, 2021 in U.S. Appl. No. 16/039,817.
USPTO; Final Office Action dated Mar. 8, 2021 in U.S. Appl. No. 16/042,791.
USPTO; Advisory Action dated May 14, 2021 in U.S. Appl. No. 16/042,791.
USPTO; Notice of Allowance dated Mar. 10, 2021 in U.S. Appl. No. 16/055,532.
USPTO; Final Office Action dated Mar. 23, 2021 in U.S. Appl. No. 16/105,745.
USPTO; Final Office Action dated Mar. 24, 2021 in U.S. Appl. No. 16/105,761.
USPTO; Advisory Action dated May 20, 2021 in U.S. Appl. No. 16/105,761.
USPTO; Final Office Action dated Mar. 18, 2021 in U.S. Appl. No. 16/105,802.
USPTO; Advisory Action dated May 27, 2021 in U.S. Appl. No. 16/105,802.
USPTO; Advisory Action dated Feb. 17, 2021 in U.S. Appl. No. 16/108,950.
USPTO; Non-Final Office Action dated Apr. 13, 2021 in U.S. Appl. No. 16/108,950.
USPTO; Notice of Allowance dated Mar. 23, 2021 in U.S. Appl. No. 16/116,708.
USPTO; Advisory Action dated Mar. 10, 2021 in U.S. Appl. No. 16/117,530.
USPTO; Non-Final Office Action dated Mar. 23, 2021 in U.S. Appl. No. 16/151,074.
USPTO; Final Office Action dated May 6, 2021 in U.S. Appl. No. 16/152,260.
USPTO; Notice of Allowance dated Feb. 24, 2021 in U.S. Appl. No. 16/167,164.
USPTO; Non-Final Office Action dated Feb. 19, 2021 in U.S. Appl. No. 16/172,535.
USPTO; Final Office Action dated May 27, 2021 in U.S. Appl. No. 16/172,535.
USPTO; Advisory Action dated Apr. 5, 2021 in U.S. Appl. No. 16/176,517.
USPTO; Notice of Allowance dated May 13, 2021 in U.S. Appl. No. 16/176,517.
USPTO; Notice of Allowance dated Feb. 19, 2021 in U.S. Appl. No. 16/183,258.
USPTO; Notice of Allowance dated Feb. 10, 2021 in U.S. Appl. No. 16/205,899.
USPTO; Non-Final Office Action dated Mar. 29, 2021 in U.S. Appl. No. 16/206,589.
USPTO; Advisory Action dated Feb. 25, 2021 in U.S. Appl. No. 16/210,922.
USPTO; Final Office Action dated Mar. 29, 2021 in U.S. Appl. No. 16/219,555.
USPTO; Non-Final Office Action dated May 2, 2021 in U.S. Appl. No. 16/240,392.
USPTO; Advisory Action dated Jan. 26, 2021 in U.S. Appl. No. 16/251,534.
USPTO; Non-Final Office Action dated Feb. 23, 2021 in U.S. Appl. No. 16/251,534.
USPTO; Non-Final Office Action dated Mar. 30, 2021 in U.S. Appl. No. 16/252,567.
USPTO; Non-Final Office Action dated Mar. 4, 2021 in U.S. Appl. No. 16/252,569.
USPTO; Non-Final Office Action dated Apr. 20, 2021 in U.S. Appl. No. 16/397,045.
USPTO; Notice of Allowance dated Mar. 10, 2021 in U.S. Appl. No. 16/400,814.
USPTO; Non-Final Office Action dated May 7, 2021 in U.S. Appl. No. 16/423,824.
USPTO; Notice of Allowance dated Apr. 28, 2021 in U.S. Appl. No. 16/453,249.
USPTO; Final Office Action dated May 20, 2021 in U.S. Appl. No. 16/468,258.
USPTO; Notice of Allowance dated Apr. 26, 2021 in U.S. Appl. No. 16/517,122.
USPTO; Final Office Action dated May 12, 2021 in U.S. Appl. No. 16/546,543.
USPTO; Non-Final Office Action dated Feb. 1, 2021 in U.S. Appl. No. 16/563,473.
USPTO; Non-Final Office Action dated May 10, 2021 in U.S. Appl. No. 16/601,593.
USPTO; Non-Final Office Action dated Feb. 24, 2021 in U.S. Appl. No. 16/637,134.
USPTO; Notice of Allowance dated Jun. 2, 2021 in U.S. Appl. No. 16/637,134.
USPTO; Notice of Allowance dated Apr. 30, 2021 in U.S. Appl. No. 16/685,787.
USPTO; Non-Final Office Action dated Apr. 5, 2021 in U.S. Appl. No. 16/704,835.
USPTO; Final Office Action dated Feb. 22, 2021 in U.S. Appl. No. 16/713,311.
USPTO; Notice of Allowance dated May 20, 2021 in U.S. Appl. No. 16/752,514.
USPTO; Notice of Allowance dated May 24, 2021 in U.S. Appl. No. 16/765,125.
USPTO; Non-Final Office Action dated Apr. 15, 2021 in U.S. Appl. No. 16/789,138.
USPTO; Notice of Allowance dated May 12, 2021 in U.S. Appl. No. 16/800,114.
USPTO; Non-Final Office Action dated Apr. 5, 2021 in U.S. Appl. No. 16/816,078.
USPTO; Non-Final Office Action dated May 19, 2021 in U.S. Appl. No. 16/828,753.
USPTO; Non-Final Office Action dated May 4, 2021 in U.S. Appl. No. 16/872,045.
USPTO; Non-Final Office Action dated May 3, 2021 in U.S. Appl. No. 16/878,443.
USPTO; Non-Final Office Action dated Dec. 31, 2020 in U.S. Appl. No. 16/924,595.
USPTO; Non-Final Office Action dated May 25, 2021 in U.S. Appl. No. 16/935,280.
USPTO; Non-Final Office Action dated Apr. 14, 2021 in U.S. Appl. No. 17/009,093.
USPTO; Ex Parte Quayle Action dated Apr. 13, 2021 in U.S. Appl. No. 29/679,620.
USPTO; Notice of Allowance dated May 19, 2021 in U.S. Appl. No. 29/702,881.
Aubin et al. “Very low temperature (450° C.) selective epitaxial growth of heavily in situ boron-doped SiGe layers” Semiconductor Science and Technology, 30, 10 pages (2015).
Barnscheidt et al. “Highly boron-doped germanium layers on Si(001) grown by carbon-mediated epitaxy” Semiconductor Science and Technology, 33, 9 pages (2018).
Belyansky et al. “Low Temperature Borophosphosilicate Glass (BPSG) Process for High Aspect Ratio Gap Fill” www.electrochem.org/dl/ma/201/pdfs/0705.pdf, downloaded May 15, 2021, 1 page.
Cheremisin et al. “UV-laser modification and selective ion-beam etching of amorphous vanadium pentoxide thin films” Phys. Status Solidi A, Applications and materials science, 206 (7), pp. 1484-1487 (2009).
Dingemans et al. “Plasma-Assisted ALD for the Conformal Deposition of SiO2: Process, Material and Electronic Properties” J of the Electrochemical Society, 159(3), H277-H285 (2012).
G02-1152 “Atomic Layer Deposition of Al2O3 with Alcohol Oxidants for Impeding Substrate Oxidation” Abstract. Oct. 16, 2019 (2019).
Imamura et al. “Cyclic C4F8 and O2 plasma etching of TiO2 for high-aspect-ratio three-dimensional devices” Template for JJAP Regular Papers, Jan. 2014, p. 29 (2014).
Kim et al. “A process for topographically selective deposition on 3D nanostructures by ion implantation” ACS Nano, 10, 4, 4451-4458 (2016).
Lee et al. “Ultraviolet light enhancement of Ta2O5 dry etch rates” J. of Vacuum Science & Technology B: Microelectronics and Nanometer Structures Processing, Measurement, and Phenomena, 18, pp. 293-295 (2000).
Musschoot et al. “Atomic layer deposition of titanium nitride from TDMAT precursor” Microelectronic Engineering, 86, pp. 72-77 (2009).
Noircler et al. “Transmission electron microscopy characterization of low temperature boron doped silicon epitaxial films” CrystEngComm, 22(33), pp. 5464-5472 (2020).
Oyama et al. “Topotactic synthesis of vanadium nitride solid foams” Journal of Materials Research vol. 8. No. 6, pp. 1450-1454 (1993).
Rimoldi et al. “Atomic Layer Deposition of Rhenium-Aluminum Oxide Thin Films and ReOx Incorporation in a Metal-Organic Framework” Applied Materials & Interfaces, 9, pp. 35067-35074 (2017).
Standard Motor Products LX249 Ignition Pick Up, Nov. 11, 2005, Amazon.com, May 10, 2021. URL: https://www.amazon.com/Standard-Motor-Products-LX249-Ignition/dp/B000C7ZTS4/ (2005).
Tao et al. “Improved performance of GeON as charge storage layer in flash memory by optimal annealing” Microelectronics Reliability, vol. 52, pp. 2597-2601 (2012).
Wirths et al. “Low temperature RPCVD epitaxial growth of Si1xGex using Si2H6 and Ge2H6” Solid-State Electronics, 88, pp. 2-9 (2013).
Yanguas-Gil et al. “Modulation of the Growth Per Cycle in Atomic Layer Deposition Using Reversible Surface Functionalization” Chemistry of Materials, 25, pp. 4849-4860 (2013).
CNIPA; Office Action dated Jul. 21, 2021 in Application No. 201610131743.1.
CNIPA; Office Action dated Jul. 23, 2021 in Application No. 201710131319.1.
CNIPA; Notice of Allowance dated Jun. 3, 2021 in Application No. 201711057929.8.
CNIPA; Office Action dated Sep. 13, 2021 in Application No. 201780076230.8.
CNIPA; Office Action dated Sep. 13, 2021 in Application No. 201780076321.1.
CNIPA; Office Action dated Apr. 30, 2021 in Application No. 201810018936.5.
CNIPA; Office Action dated Apr. 16, 2021 in Application No. 201810116717.0.
CNIPA; Notice of Allowance dated Sep. 15, 2021 in Application No. 201810116717.0.
CNIPA; Office Action dated May 26, 2021 in Application No. 201810215131.X.
CNIPA; Office Action dated Jun. 16, 2021 in Application No. 201810344382.8.
CNIPA; Notice of Allowance dated Oct. 11, 2021 in Application No. 201810344382.8.
CNIPA; Office Action dated Jul. 5, 2021 in Application No. 201810530514.6.
CNIPA; Office Action dated Jun. 30, 2021 in Application No. 201810755771.X.
CNIPA; Office Action dated Sep. 23, 2021 in Application No. 201880048547.5.
CNIPA; Office Action dated May 19, 2021 in Application No. 201880072606.2.
CNIPA; Office Action dated May 31, 2021 in Application No. 201910857144.1.
CNIPA; Office Action dated Jun. 2, 2021 in Application No. 201910920881.1.
CNIPA; Office Action dated Jul. 5, 2021 in Application No. 201911042495.3.
CNIPA; Office Action dated Apr. 27, 2021 in Application No. 201911250100.9.
CNIPA; Office Action dated Jul. 7, 2021 in Application No. 201980011788.7.
CNIPA; Notice of Allowance dated Jun. 16, 2021 in Application No. 202130111248.6.
EPO; Extended European Search Report dated Aug. 11, 2021 in Application No. 21169226.4.
JPO; Notice of Allowance dated Aug. 11, 2021 in Application No. 2018-024655.
JPO; Office Action dated Aug. 2, 2021 in Application No. 2019-504674.
JPO; Office Action dated Sep. 10, 2021 in Application No. 2019-531445.
JPO; Notice of Allowance dated Jun. 30, 2021 in Application No. 2021-004208.
KIPO; Office Action dated Jun. 28, 2021 in Application No. 10-2014-0027217.
KIPO; Notice of Allowance dated May 27, 2021 in Application No. 10-2014-0105478.
KIPO; Notice of Allowance dated Aug. 17, 2021 in Application No. 10-2014-0122903.
KIPO; Notice of Allowance dated Sep. 8, 2021 in Application No. 10-2014-0136089.
KIPO; Notice of Allowance dated Jul. 6, 2021 in Application No. 10-2014-0145220.
KIPO; Notice of Allowance dated Sep. 23, 2021 in Application No. 2014-0156196.
KIPO; Notice of Allowance dated Jul. 21, 2021 in Application No. 10-2015-0025314.
KIPO; Office Action dated May 19, 2021 in Application No. 10-2015-0036819.
KIPO; Office Action dated Jun. 23, 2021 in Application No. 10-2015-0037658.
KIPO; Office Action dated Sep. 6, 2021 in Application No. 10-2015-0046393.
KIPO; Office Action dated Jun. 10, 2021 in Application No. 2015-61391.
KIPO; Office Action dated Sep. 3, 2021 in Application No. 2017-37847.
KIPO; Office Action dated Aug. 2, 2021 in Application No. 2017-43865.
KIPO; Office Action dated Oct. 1, 2021 in Application No. 2017-43919.
KIPO; Office Action dated Sep. 28, 2021 in Application No. 2017-49172.
KIPO; Notice of Allowance dated Sep. 28, 2021 in Application No. 2017-54647.
KIPO; Office Action dated in Aug. 30, 2021 in Application No. 2017-81515.
KIPO; Office Action dated Sep. 10, 2021 in Application No. 2017-86083.
KIPO; Office Action dated Jun. 29, 2021 in Application No. 10-2017-0066979.
KIPO; Notice of Allowance dated Jun. 24, 2021 in Application No. 10-2019-0044213.
KIPO; Office Action dated Jun. 17, 2021 in Application No. 10-2021-0051860.
KIPO; Office Action dated Aug. 18, 2021 in Application No. 10-2021-0090283.
KIPO; Notice of Allowance dated Sep. 2, 2021 in Application No. 30-2020-0047043.
TIPO; Office Action dated Jun. 22, 2021 in Application No. 104108277.
TIPO; Notice of Allowance dated Sep. 22, 2021 in Application No. 104108277.
TIPO; Office Action dated Jun. 2, 2021 in Application No. 105129977.
TIPO; Notice of Allowance dated Sep. 9, 2021 in Application No. 105129977.
TIPO; Notice of Allowance dated Jun. 4, 2021 in Application No. 105131896.
TIPO; Notice of Allowance dated Jul. 30, 2021 in Application No. 105134275.
TIPO; Notice of Allowance dated Feb. 24, 2021 in Application No. 106113604.
TIPO; Notice of Allowance dated Sep. 3, 2021 in Application No. 106115126.
TIPO; Office Action dated Jun. 21, 2021 in Application No. 106120902.
TIPO; Notice of Allowance dated Jun. 30, 2021 in Application No. 106121797.
TIPO; Notice of Allowance dated Sep. 1, 2021 in Application No. 106122231.
TIPO; Notice of Allowance dated Jun. 3, 2021 in Application No. 106123203.
TIPO; Notice of Allowance dated Aug. 24, 2021 in Application No. 106124129.
TIPO; Notice of Allowance dated Jul. 28, 2021 in Application No. 106129491.
TIPO; Notice of Allowance dated Aug. 10, 2021 in Application No. 106129971.
TIPO; Office Action dated Jun. 15, 2021 in Application No. 106133152.
TIPO; Notice of Allowance dated Oct. 12, 2021 in Application No. 106135925.
TIPO; Office Action dated Jul. 13, 2021 in Application No. 106138996.
TIPO; Notice of Allowance dated Sep. 24, 2021 in Application No. 106143559.
TIPO; Office Action dated Aug. 5, 2021 in Application No. 106143566.
TIPO; Office Action dated May 26, 2021 in Application No. 106143568.
TIPO; Notice of Allowance dated Jul. 30, 2021 in Application No. 106143570.
TIPO; Office Action dated Jun. 7, 2021 in Application No. 107103230.
TIPO; Office Action dated Aug. 10, 2021 in Application No. 107103230.
TIPO; Office Action dated Sep. 8, 2021 in Application No. 107105788.
TIPO; Office Action dated Aug. 3, 2021 in Application No. 107105982.
TIPO; Office Action dated Aug. 16, 2021 in Application No. 107114888.
TIPO; Office Action dated Sep. 28, 2021 in Application No. 109112983.
TIPO; Office Action dated Sep. 13, 2021 in Application No. 109119438.
TIPO; Office Action dated Oct. 18, 2021 in Application No. 109300594.
TIPO; Notice of Allowance dated Jun. 9, 2021 in Application No. 109303437.
TIPO; Notice of Allowance dated Oct. 1, 2021 in Application No. 110118827.
TIPO; Notice of Allowance dated Jun. 30, 2021 in Application No. 110301018.
TIPO; Notice of Allowance dated Jul. 29, 2021 in Application No. 110301101.
TIPO; Notice of Allowance dated Jul. 27, 2021 in Application No. 110302670.
USPTO; Final Office Action dated Aug. 4, 2021 in U.S. Appl. No. 14/219,879.
USPTO; Non-Final Office Action dated Jun. 10, 2021 in U.S. Appl. No. 15/262,990.
USPTO; Final Office Action dated Oct. 1, 2021 in U.S. Appl. No. 15/262,990.
USPTO; Non-Final Office Action dated Jul. 9, 2021 in U.S. Appl. No. 15/286,503.
USPTO; Notice of Allowance dated Jun. 29, 2021 in U.S. Appl. No. 15/377,439.
USPTO; Non-Final Office Action dated Jun. 25, 2021 in U.S. Appl. No. 15/380,909.
USPTO; Final Office Action dated Jun. 21, 2021 in U.S. Appl. No. 15/380,921.
USPTO; Advisory Action dated Aug. 30, 2021 in U.S. Appl. No. 15/380,921.
USPTO; Non-Final Office Action dated Oct. 6, 2021 in U.S. Appl. No. 15/380,921.
USPTO; Advisory Action dated Jul. 27, 2021 in U.S. Appl. No. 15/402,993.
USPTO; Final Office Action dated Jun. 9, 2021 in U.S. Appl. No. 15/491,726.
USPTO; Advisory Action dated Aug. 24, 2021 in U.S. Appl. No. 15/491,726.
USPTO; Non-Final Office Action dated Sep. 28, 2021 in U.S. Appl. No. 15/491,726.
USPTO; Notice of Allowance dated Aug. 25, 2021 in U.S. Appl. No. 15/611,707.
USPTO; Non-Final Office Action dated Sep. 16, 2021 in U.S. Appl. No. 15/636,307.
USPTO; Advisory Action dated Jun. 11, 2021 in U.S. Appl. No. 15/690,017.
USPTO; Non-Final Office Action dated Jun. 17, 2021 in U.S. Appl. No. 15/690,017.
USPTO; Final Office Action dated Jul. 15, 2021 in U.S. Appl. No. 15/726,959.
USPTO; Advisory Action dated Sep. 21, 2021 in U.S. Appl. No. 15/726,959.
USPTO; Notice of Allowance dated Sep. 15, 2021 in U.S. Appl. No. 15/835,328.
USPTO; Advisory Action dated Jun. 11, 2021 in U.S. Appl. No. 15/909,705.
USPTO; Notice of Allowance dated Jun. 4, 2021 in U.S. Appl. No. 15/923,834.
USPTO; Final Office Action dated Jun. 28, 2021 in U.S. Appl. No. 15/925,532.
USPTO; Advisory Action dated Aug. 27, 2021 in U.S. Appl. No. 15/925,532.
USPTO; Non-Final Office Action dated Oct. 6, 2021 in U.S. Appl. No. 15/925,532.
USPTO; Non-Final Office Action dated Jun. 16, 2021 in U.S. Appl. No. 15/940,729.
USPTO; Notice of Allowance dated Sep. 28, 2021 in U.S. Appl. No. 15/940,729.
USPTO; Non-Final Office Action dated Aug. 2, 2021 in U.S. Appl. No. 15/962,980.
USPTO; Non-Final Office Action dated Oct. 4, 2021 in U.S. Appl. No. 15/967,146.
USPTO; Final Office Action dated Aug. 3, 2021 in U.S. Appl. No. 15/974,948.
USPTO; Advisory Action dated Oct. 21, 2021 in U.S. Appl. No. 15/974,948.
USPTO; Final Office Action dated Oct. 12, 2021 in U.S. Appl. No. 15/996,286.
USPTO; Non-Final Office Action dated Jul. 9, 2021 in U.S. Appl. No. 15/997,445.
USPTO; Final Office Action dated Aug. 5, 2021 in U.S. Appl. No. 16/000,109.
USPTO; Final Office Action dated Oct. 20, 2021 in U.S. Appl. No. 16/000,125.
USPTO; Final Office Action dated Sep. 3, 2021 in U.S. Appl. No. 16/004,041.
USPTO; Non-Final Office Action dated Oct. 22, 2021 in U.S. Appl. No. 16/042,791.
USPTO; Non-Final Office Action dated Sep. 28, 2021 in U.S. Appl. No. 16/105,745.
USPTO; Non-Final Office Action dated Sep. 29, 2021 in U.S. Appl. No. 16/105,761.
USPTO; Non-Final Office Action dated Jun. 25, 2021 in U.S. Appl. No. 16/105,802.
USPTO; Final Office Action dated Jul. 27, 2021 in U.S. Appl. No. 16/108,950.
USPTO; Advisory Action dated Oct. 1, 2021 in U.S. Appl. No. 16/108,950.
USPTO; Non-Final Office Action dated Jun. 18, 2021 in U.S. Appl. No. 16/117,530.
USPTO; Final Office Action dated Jul. 8, 2021 in U.S. Appl. No. 16/151,074.
USPTO; Notice of Allowance dated Sep. 17, 2021 in U.S. Appl. No. 16/151,074.
USPTO; Non-Final Office Action dated Sep. 16, 2021 in U.S. Appl. No. 16/152,260.
USPTO; Advisory Action dated Aug. 2, 2021 in U.S. Appl. No. 16/172,535.
USPTO; Non-Final Office Action dated Oct. 15, 2021 in U.S. Appl. No. 16/172,535.
USPTO; Final Office Action dated Jun. 14, 2021 in U.S. Appl. No. 16/202,941.
USPTO; Advisory Action dated Aug. 16, 2021 in U.S. Appl. No. 16/202,941.
USPTO; Non-Final Office Action dated Sep. 20, 2021 in U.S. Appl. No. 16/202,941.
USPTO; Final Office Action dated Jul. 26, 2021 in U.S. Appl. No. 16/206,589.
USPTO; Notice of Allowance dated Sep. 13, 2021 in U.S. Appl. No. 16/206,589.
USPTO; Non-Final Office Action dated Aug. 25, 2021 in U.S. Appl. No. 16/210,922.
USPTO; Final Office Action dated Sep. 1, 2021 in U.S. Appl. No. 16/240,392.
USPTO; Notice of Allowance dated Oct. 15, 2021 in U.S. Appl. No. 16/240,392.
USPTO; Final Office Action dated Sep. 7, 2021 in U.S. Appl. No. 16/251,534.
USPTO; Final Office Action dated Aug. 18, 2021 in U.S. Appl. No. 16/252,567.
USPTO; Final Office Action dated Jul. 21, 2021 in U.S. Appl. No. 16/252,569.
USPTO; Advisory Action dated Jul. 15, 2021 in U.S. Appl. No. 16/468,258.
USPTO; Non-Final Office Action dated Oct. 21, 2021 in U.S. Appl. No. 16/468,258.
USPTO; Advisory Action dated Jul. 8, 2021 in U.S. Appl. No. 16/546,543.
USPTO; Ex Parte Quayle Action dated Aug. 6, 2021 in U.S. Appl. No. 16/563,473.
USPTO; Notice of Allowance dated Sep. 30, 2021 in U.S. Appl. No. 16/563,473.
USPTO; Non-Final Office Action dated Oct. 5, 2021 in U.S. Appl. No. 16/588,807.
USPTO; Notice of Allowance dated Oct. 18, 2021 in U.S. Appl. No. 16/601,593.
USPTO; Non-Final Office Action dated Jun. 11, 2021 in U.S. Appl. No. 16/671,847.
USPTO; Non-Final Office Action dated Jun. 24, 2021 in U.S. Appl. No. 16/673,860.
USPTO; Non-Final Office Action dated Sep. 28, 2021 in U.S. Appl. No. 16/692,859.
USPTO; Notice of Allowance dated Jul. 20, 2021 in U.S. Appl. No. 16/704,835.
USPTO; Non-Final Office Action dated Aug. 31, 2021 in U.S. Appl. No. 16/712,707.
USPTO; Non-Final Office Action dated Sep. 21, 2021 in U.S. Appl. No. 16/736,336.
USPTO; Final Office Action dated Sep. 15, 2021 in U.S. Appl. No. 16/789,138.
USPTO; Non-Final Office Action dated Jun. 24, 2021 in U.S. Appl. No. 16/792,058.
USPTO; Notice of Allowance dated Oct. 19, 2021 in U.S. Appl. No. 16/792,058.
USPTO; Non-Final Office Action dated Oct. 6, 2021 in U.S. Appl. No. 16/792,544.
USPTO; Notice of Allowance dated Sep. 27, 2021 in U.S. Appl. No. 16/792,571.
USPTO; Non-Final Office Action dated Aug. 17, 2021 in U.S. Appl. No. 16/797,346.
USPTO; Notice of Allowance dated Jul. 21, 2021 in U.S. Appl. No. 16/816,078.
USPTO; Non-Final Office Action dated Jun. 23, 2021 in U.S. Appl. No. 16/827,012.
USPTO; Non-Final Office Action dated Feb. 23, 2021 in U.S. Appl. No. 16/827,506.
USPTO; Notice of Allowance dated May 27, 2021 in U.S. Appl. No. 16/827,506.
USPTO; Final Office Action dated Oct. 6, 2021 in U.S. Appl. No. 16/828,753.
USPTO; Non-Final Office Action dated Jul. 28, 2021 in U.S. Appl. No. 16/835,283.
USPTO; Non-Final Office Action dated Oct. 4, 2021 in U.S. Appl. No. 16/840,960.
USPTO; Non-Final Office Action dated Aug. 3, 2021 in U.S. Appl. No. 16/849,793.
USPTO; Non-Final Office Action dated Jun. 15, 2021 in U.S. Appl. No. 16/861,144.
USPTO; Final Office Action dated Sep. 17, 2021 in U.S. Appl. No. 16/861,144.
USPTO; Non-Final Office Action dated Sep. 1, 2021 in U.S. Appl. No. 16/867,385.
USPTO; Final Office Action dated Oct. 7, 2021 in U.S. Appl. No. 16/872,045.
USPTO; Final Office Action dated Oct. 14, 2021 in U.S. Appl. No. 16/878,443.
USPTO; Non-Final Office Action dated Oct. 4, 2021 in U.S. Appl. No. 16/886,405.
USPTO; Non-Final Office Action dated Jul. 28, 2021 in U.S. Appl. No. 16/888,423.
USPTO; Non-Final Office Action dated Oct. 13, 2021 in U.S. Appl. No. 16/893,206.
USPTO; Notice of Allowance dated Jun. 17, 2021 in U.S. Appl. No. 16/924,595.
USPTO; Non-Final Office Action dated Jul. 27, 2021 in U.S. Appl. No. 16/930,193.
USPTO; Non-Final Office Action dated Jun. 25, 2021 in U.S. Appl. No. 16/930,305.
USPTO; Non-Final Office Action dated Sep. 14, 2021 in U.S. Appl. No. 16/932,707.
USPTO; Non-Final Office Action dated Oct. 4, 2021 in U.S. Appl. No. 16/935,275.
USPTO; Notice of Allowance dated Sep. 22, 2021 in U.S. Appl. No. 16/935,280.
USPTO; Non-Final Office Action dated Aug. 23, 2021 in U.S. Appl. No. 16/938,868.
USPTO; Non-Final Office Action dated Oct. 12, 2021 in U.S. Appl. No. 16/944,763.
USPTO; Non-Final Office Action dated Aug. 19, 2021 in U.S. Appl. No. 16/992,806.
USPTO; Non-Final Office Action dated Jul. 7, 2021 in U.S. Appl. No. 16/999,065.
USPTO; Final Office Action dated Oct. 21, 2021 in U.S. Appl. No. 16/999,065.
USPTO; Final Ofiice Action dated Jul. 23, 2021 in U.S. Appl. No. 17/009,093.
USPTO; Advisory Action dated Oct. 5, 2021 in U.S. Appl. No. 17/009,093.
USPTO; Non-Final Office Action dated Sep. 28, 2021 in U.S. Appl. No. 17/023,129.
USPTO; Notice of Allowance dated Oct. 14, 2021 in U.S. Appl. No. 17/024,092.
USPTO; Notice of Allowance dated Oct. 4, 2021 in U.S. Appl. No. 17/028,066.
USPTO; Non-Final Office Action dated Sep. 10, 2021 in U.S. Appl. No. 17/038,514.
USPTO; Non-Final Office Action dated Oct. 22, 2021 in U.S. Appl. No. 17/073,544.
USPTO; Non-Final Office Action dated Sep. 30, 2021 in U.S. Appl. No. 17/093,224.
USPTO; Non-Final Office Action dated Sep. 22, 2021 in U.S. Appl. No. 17/126,275.
USPTO; Non-Final Office Action dated Sep. 23, 2021 in U.S. Appl. No. 17/254,111.
USPTO; Non-Final Office Action dated Sep. 27, 2021 in U.S. Appl. No. 17/254,366.
USPTO; Notice of Allowance dated Jul. 1, 2021 in U.S. Appl. No. 29/679,620.
USPTO; Notice of Allowance dated Jul. 9, 2021 in U.S. Appl. No. 29/692,490.
USPTO; Non-Final Office Action dated Jul. 14, 2021 in U.S. Appl. No. 29/695,044.
USPTO; Notice of Allowance dated Jun. 8, 2021 in U.S. Appl. No. 29/696,472.
USPTO; Notice of Allowance dated Sep. 21, 2021 in U.S. Appl. No. 29/702,865.
Alen et al. “Atomic layer deposition of molybdenum nitride thin films for cu metallizations” J of The Electrochemical Society, 152(5) G361-G366 (2005).
Best et al. “Complex Halides of the Transition Metals. 24.1 Reactions of Dimeric Molybdenum (II) Halide Complexes Containing Strong Metal-Metal Bonds with Bidentate Tertiary Phosphines and Arsines” Inorganic Chemistry, vol. 17, No. 1, pp. 99-104 (1978).
Blakeney et al. “Atomic Layer Deposition of Aluminum Metal Films Using a Thermally Stable Aluminum Hydride Reducing Agent” Chem. Mater., 30, pp. 1844-1848 (2018).
Buitrago et al. “SnOx high-efficiency EUV interference lithography gratings towards the ultimate resolution in photolithography” Abstract, 1 page (2016).
Buitrago et al. “State-of-the-art EUV materials and processes for the 7 nm node and beyond” Proc of SPIE, vol. 10143, 8 pages (2017).
Cheng et al. “Improved High-Temperature Leakage in High-Density MIM Capcitors by Using a TiLaO Dielectric and an Ir Electrode” IEEE Electron Device Letters, vol. 28, No. 12, 3 pages (2007).
Firestop Support Plate, Type B, 6 In Apr. 4, 2012, Amazon. Com, May 10, 2021, https://www.amazon.com/AmeriVent-Firestop-Support-Plate-Type/dp/B007R7W951/ (2012).
Gertsch et al. “SF4 as the Fluorination Reactant for Al2O3 and VO2 Thermal Atomic Layer Etching” Chem. Mater., 31, pp. 3624-3635 (2019).
Han et al. “Synthesis and characterization of novel zinc precursors for ZnO thin film deposition by atomic layer deposition” Dalton Transactions 49.14 (2020): 4306-4314.
Hayashi et al. “2,2-Difluoro-1,3-dimethylimidazolidine (DFI). A new fluorinating agent” Chem. Commun. pp. 1618-1619 (2002).
Imai et al. “Energetic stability and magnetic moment of tri-, tetra-, and octa-ferromagnetic element nitrides predicted by first-principle calculations” J of Alloys and Compounds, vol. 611, 19 pages (2019).
Jacoby “Chemical deposition methods to the rescue” Cen. Acs. Org., pp. 29-32 (2018).
Jiang et al. “Sensitizer for EUV Chemically Amplified Resist: Metal versus Halogen” J of Photopolymer Science and Technology, vol. 32, No. 1, pp. 21-25 (2019).
Kang et al. “Optical Performance of Extreme Ultraviolet Lithography Mask with an Indium Tin Oxide Absorber” J of Nanoscience and Nanotechnology, vol. 12, pp. 3330-3333 (2012).
Kim et al. “Atomic layer deposition of transition metals for silicide contact formation: Growth characteristics and silicidation” Microelectronic Engineering, 106, pp. 69-75 (2013).
Lim et al. “Atomic layer deposition of transition metals” Nature Materials, vol. 2 pp. 749-754 (2003).
Maina et al. “Atomic layer deposition of transition metal films and nanostructures for electronic and catalytic applications” Critical Reviews in Solid State and Materials Sciences, Abstract, 2 pages (2020).
Miikkulainen et al. “Crystallinity of inorganic films grown by atomic layer deposition: Overview and general trends” Journal of Applied Physics, 112, 102 pages (2013).
Niskanen et al. “Radical-enhanced atomic layer deposition of metallic copper thin films” Journal of the Electrochemical Society 152(1) pp. G25-G28 (2004).
O'Hanlon “A User's Guide to Vacuum Technology” Third Edition, Chapter 19, pp. 359-378 (2003).
Ovanesyan et al. “Atomic Layer Deposition of SiCxNy Using Si2Cl6 and CH3NH2 Plasma” Chem. Mater. 2017, 29, pp. 6269-6278 (2017).
Park et al. “Superfilling CVD of copper using a catalytic surfactant” Proceedings of the IEEE 2001 International Interconnect Technology Conference, 3 pages (2001).
Petrov et al. “1,1,2,2-Tetrafluoroethyl-N,N-dimethylamine: a new selective fluorinating agent” J of Fluorine Chemistry, 109, pp. 25-31 (2001).
Popov et al. “Atomic Layer Deposition of PbI2 Thin Films” Chem. Mater. 31, pp. 1101-1109 (2019).
Popovici et al. “High-performance (EOT<0.4nm, Jg˜10-7 A/cm2) ALD-deposited Ru\SrTiO3 stack for next generations DRAM pillar capacitor” 2018 IEEE International Electron Devices Meeting (IEDM), 4 pages (2018).
Puurunen “Surface Chemistry of Atomic Layer Depostion: A Case Study for the Trimethylaluminum/Water Process” Journal of Applied Physics, 97, 55 pages (2005).
Rahemi et al. “Variation in electron work function with temperature and its effect on the Young's modulus of metals” Scripta Materialia, 99, pp. 41-44 (2015).
SciFinder Search Results on hydrazido-based precursor for boron nitride films, search conducted Nov. 5, 2020, 5 pages (2020).
Shiba et al. “Stable yttrium oxyfluoride used in plasma process chamber” J. Vac. Sci. Technol. A, 35(2), 6 pages (2017).
Shigemoto et al. “Thermal cleaning of silicon nitride with fluorine and additive mixture” 1 page (2007).
Takaoka et al. “F-Propene-Dialkylamine Reaction Products as Fluorinating Agents” Bulletin of the Chemical Socity of Japan, vol. 52 (11), pp. 3377-3380 (1979).
Tsoutsou et al. “Atomic layer deposition of LaxZr1—xO2-d (x=0.25) high-k dielectrics for advanced gate stacks” Applied Physics Letters, 94, 3 pages (2009).
US PPA U.S. Appl. No. 60/545,181, filed Feb. 13, 2004 in the names of Matthew G. Goodman et al., and entitled “Forced Flow Susceptor with Exit Holes and Veins for Improvided Process” pp. 1-15 (2004).
US PPA U.S. Appl. No. 60/591,258, filed Jul. 26, 2004 in the names of Jeroen Stoutyesdijk et al., and entitled “Susceptor Support for Eliminating Backside Nodules” pp. 1-71 (2004).
US PPA U.S. Appl. No. 62/504,470, filed May 10, 2017 in the names of Jennifer Y. Sun et al., and entitled “Metal-Oxy-Fluoride Films for Chamber Components” pp. 1-82 (2017).
Van Asselt et al. “New Palladium Complexes of Cis-Fixed Bidentate Nitrogen Ligands as Catalysts for Carbon-Carbon Bond Formation” Organometallics, 11, pp. 1999-2001 (1992).
Van Asselt et al. “On the Mechanism of Formation of Homocoupled Products in the Carbon-Carbon Cross-Coupling Reaction Catalyzed by Palladium Complexes Containing Rigid Bidentate Nitrogen Ligands” Organometallics, 13, pp. 1972-1980 (1994).
Vayrynen et al. “Atomic Layer Deposition of Nickel Nitride Thin Films Using NiCL2 (TMPDA) and Tert-Butylhydrazine as Precursors” Phy. Status Solidi A, 216, 9 pages (2019).
Vesters et al. “Sensitizers in EUV Chemically Amplified Resist: Mechanism of sensitivity improvement” Proc. SPIE 10583 Extreme Ultraviolet (EUV) Lithography IX, 1058307, 11 pages (2018).
Wilklow-Marnell et al. “First-row transitional-metal oxalate resists for EUV” J. Micro/Nanolith. MEMS MOEMS 17(4) Oct.-Dec. 2018, 9 pages (2018).
Zhang et al. “Mechanical Stability of Air-gap Interconnects” Proc. Future Fab International, pp. 81-87 (2008).
Zientara et al. Journal of the European Ceramic Society, 27, Abstract, 1 page (2007).
Hayashi et al. “Spectroscopic properties of nitrogen doped hydrogenated amorphous carbon films grown by radio frequency plasma-enhanced chemical vapor deposition,” Journal of Applied Physics. vol. 89, No. 12, pp. 7924-7931 (2001).
Jung et al., “Double Patterning of Contact Array with Carbon Polymer,” Proc. of SPIE, 6924, 69240C, 1-10 (2008).
Miller et al. “Carbon nitrides: synthesis and characterization of a new class of functional materials,” Phys. Chem. Chem. Phys., 19, pp. 15613-15638 (2017).
Related Publications (1)
Number Date Country
20210320003 A1 Oct 2021 US
Provisional Applications (1)
Number Date Country
63009318 Apr 2020 US